0001 1 CUYAHOGA COUNTY, OHIO COURT OF COMMON PLEAS 2 3 - - - 4 SHANNON SULLIVAN, et al., : CASE NO. 5 Plaintiff, : CV-09-697617 : 6 vs. : : 7 CLEVELAND CLINIC FOUNDATION, : Defendant. : 8 9 - - - 10 March 17, 2011 11 - - - 12 13 Oral deposition of JONATHAN D. 14 MORENO, Ph.D., taken at the offices of the 15 Center for Bioethics, University City Science 16 Center, 3401 Market Street, Suite 320, 17 Philadelphia, Pennsylvania 19104, beginning at 18 11:00 a.m., before Cheryl L. Goldfarb, a 19 Registered Professional Reporter and an 20 approved reporter of the United States District 21 Court. 22 - - - 23 24 25 0002 1 A P P E A R A N C E S : 2 3 BECKER & MISHKIND CO., L.P.A. BY: DAVID A. KULWICKI, ESQUIRE 4 1660 West Second Street Suite 660 5 Cleveland, Ohio 44113 216.241.2600 6 dkulwicki@beckermishkind.com Representing the Plaintiff 7 8 ROETZEL & ANDRESS 9 BY: ANNA MOORE CARULAS, ESQUIRE 1375 East Ninth Street 10 Ninth Floor Cleveland, Ohio 44114 11 216.615.7401 acarulas@ralaw.com 12 Representing the Defendant 13 - - - 14 15 16 17 18 19 20 21 22 23 24 25 0003 1 I N D E X 2 - - - 3 WITNESS: JONATHAN D. MORENO, Ph.D. 4 QUESTIONED BY: PAGE: 5 MS. CARULAS 5 6 MR. KULWICKI 140 7 - - - 8 E X H I B I T S 9 NUMBER DESCRIPTION MARKED FOR ID 10 Exhibit A Letter dated June 2, 2010 8 11 Exhibit B Letter dated December 20, 10 12 2010 13 Exhibit C Letter dated January 3, 10 2011 14 Exhibit D Copy of Ohio Revised Code 17 15 Annotated, Section 2317.54 16 Exhibit E Article entitled, "Remote 20 Magnetic Navigation," 17 by Di Biase 18 Exhibit F Five-page document printed 24 from Cleveland Clinic Web site 19 Exhibit G Report dated January 7, 32 20 2011 21 Exhibit H Curriculum vitae 47 22 - - - 23 24 25 0004 1 DEPOSITION SUPPORT INDEX 2 3 DIRECTION TO WITNESS NOT TO ANSWER 4 Page Line 5 (None) 6 7 8 REQUEST FOR PRODUCTION OF DOCUMENTS 9 Page Line Description 10 (None) 11 12 13 STIPULATIONS 14 Page Line 15 (Pursuant to Ohio law) 16 17 18 QUESTIONS MARKED 19 Page Line 20 (None) 21 22 23 24 25 0005 1 - - - 2 JONATHAN D. MORENO, Ph.D., after 3 having been first duly sworn, was 4 examined and testified as follows: 5 - - - 6 MS. CARULAS: I would like to 7 just go ahead and put on the record that 8 I do object to this testimony pursuant to 9 the motions that we have filed as to the 10 qualifications of the witness. But I am 11 going ahead, given the judge's limited 12 ruling as far as discoverability. 13 - - - 14 EXAMINATION 15 - - - 16 BY MS. CARULAS: 17 Q. Would you please state your full 18 name for the record? 19 A. My full name is Jonathan David 20 Moreno. 21 Q. Sir, you have brought your 22 entire file with you -- 23 A. I have. 24 Q. -- is that correct? 25 A. Yes. 0006 1 Q. Any portion of your file that is 2 not here? 3 A. No. 4 Q. Anything that you've received 5 that is not in this stack? 6 A. There is one work product from 7 Mr. Kulwicki, lawyer's work product, that is 8 not in this stack. 9 Q. All right. And what was that 10 lawyer's work product? 11 A. It was a statement about the 12 principal issues in the case. 13 Q. When did you receive this 14 statement? 15 A. Several days ago. 16 Q. So sometime in March of 2011? 17 A. Yes. 18 Q. Had you ever seen it prior to 19 that? 20 A. Not that particular document. 21 Q. Had you seen another what you 22 are deeming work product prior to that? 23 A. I called it work product because 24 that was the way it was labeled on the 25 document. 0007 1 I have not -- there's nothing 2 else that is not physically present here that I 3 have -- that I have seen -- 4 Q. All right. 5 A. -- from Mr. Kulwicki, other than 6 e-mail messages that did not contain anything 7 except arrangements about times to talk and so 8 forth. 9 Q. All right. So as far as this 10 statement that you received several days ago, 11 how many pages was that statement? 12 A. Gosh, maybe a dozen pages, 13 something like that. 14 Q. A dozen? 15 A. A dozen pages, double spaced, 16 something like that. 17 Q. Did you read it? 18 A. I did. 19 Q. Was there anything in that that 20 you disagreed with? 21 A. Nothing relevant to my testimony 22 that I disagreed with. 23 Q. Were there things in it that 24 you -- 25 A. Some things that I didn't have 0008 1 knowledge about, medical issues that I don't 2 pretend to present myself as a medical expert 3 on those issues. 4 Q. So besides this dozen-page 5 statement that you received -- that you read, 6 correct? 7 A. Yes. 8 Q. -- have you received any other 9 types of statements or summaries from 10 Mr. Kulwicki? 11 A. Nothing that isn't present 12 before us. 13 Q. Now, when was it that you were 14 first contacted about this case? 15 A. Gosh, I'm just trying to 16 recollect. Six or eight months ago, perhaps. 17 - - - 18 (Whereupon, Exhibit A is marked 19 for identification.) 20 - - - 21 BY MS. CARULAS: 22 Q. I do have some letters here that 23 you brought with you. I've marked as 24 Exhibit A, a letter dated June 2nd, 2010 that 25 is from Mr. Kulwicki to you; is that correct? 0009 1 A. Yes, ma'am. 2 Q. Did you receive a phone call 3 from him prior to you receiving this letter? 4 A. I -- if memory serves, we did 5 talk on the phone before I received that. 6 Q. Do you know how it is that 7 Mr. Kulwicki found you? 8 A. I don't. Oh, well, so I believe 9 that somebody -- a friend of Mr. Kulwicki's 10 knew my name somehow or a nurse. But I -- I 11 can't specify. 12 Q. Had you ever worked with 13 Mr. Kulwicki before? 14 A. No. 15 Q. Besides Mr. Kulwicki, have you 16 spoken with anyone else about this case? 17 A. No. 18 Q. There is a nurse who was working 19 on this case by the name of Michelle Mahon. 20 Do you -- 21 A. I don't believe we -- I may be 22 mistaken. I don't think we spoke. 23 Q. Do you know her? 24 A. No. 25 Q. Or had any dealings with her 0010 1 before? 2 A. No. 3 - - - 4 (Whereupon, Exhibit B is marked 5 for identification.) 6 - - - 7 BY MS. CARULAS: 8 Q. Then subsequent to that, I've 9 marked as Exhibit B, a letter sent on 10 December 20th, 2010 from Mr. Kulwicki, listing 11 some items sent, correct? 12 A. Yes, ma'am. 13 - - - 14 (Whereupon, Exhibit C is marked 15 for identification.) 16 - - - 17 BY MS. CARULAS: 18 Q. And then Exhibit C, which is a 19 letter dated January 3rd, 2011, enclosing some 20 additional materials, correct? 21 A. Yes, ma'am. 22 Q. And you say any e-mails back and 23 forth would have just been logistics? 24 A. Yes, ma'am. 25 Q. All right. Now, looking in your 0011 1 file, just for some house keeping purposes, it 2 looked like the only expert report of an expert 3 in this case that you were sent is that of 4 Dr. Conomy. 5 A. That is the only expert -- 6 everything that is before you is what I 7 received. And I don't know how to characterize 8 it. If you characterize it as an expert 9 report, that's fine with me. 10 Q. This is a letter of a Jack 11 Conomy, who is a neurologist. 12 You've read this report? 13 A. Yes. 14 Q. To your knowledge -- and I'll 15 let you go through if you see -- are you aware 16 of receiving the reports of any other experts 17 in this case? 18 A. I'm only aware of receiving the 19 material on the table. I've not received -- 20 I'm not aware of receiving any other reports. 21 Q. Did you the summary from 22 Mr. Kulwicki give you any indication as to who 23 were the other experts in the case? 24 A. I don't believe they did, no. 25 Q. Has Mr. Kulwicki told you about 0012 1 any of the other experts in the case? 2 A. He mentioned that a -- one of 3 the other experts happens also to be at the 4 University of Pennsylvania. But I don't know 5 that gentleman. 6 Q. So besides that expert from the 7 University of Pennsylvania, you're not familiar 8 with who any of the other experts are in this 9 case -- 10 A. No, ma'am. 11 Q. -- or the substance of their 12 opinions -- 13 A. No. 14 Q. -- fair? All right. 15 We have some depositions in this 16 case, and I'm just going to note here that you 17 have the deposition of Dr. Burkhardt. 18 You've read that, I assume? 19 A. Yes, ma'am. 20 Q. You had it open from Pages 86 21 through 89. 22 Any particular reason for that? 23 A. I would have to look at the 24 pages. 25 Q. Okay (handing). 0013 1 A. No, I don't think there's any -- 2 other than personal curiosity, which they're 3 describing some of the technicalities of the 4 procedure, there's no particular reason it was 5 open to that page. 6 Q. We then have the deposition of 7 Stacy Poe. 8 Did you read her testimony? 9 A. Yes, I did. 10 Q. And you have a number of 11 different stickies on there. I'm just going to 12 have it for the record, because I'm not going 13 to have it copied again, but you have stickies 14 on Pages 66, 72, 73, 75, correct? 15 A. (Witness nodding head.) 16 Q. I just want to make sure you're 17 agreeing. 18 A. Yes. I'm sorry. I don't 19 mean -- I know that we get warned not to give 20 nods -- 21 Q. Yes, that's fine. 22 A. -- but verbal responses. Yes. 23 Q. That's fine. On 88 and 89, 24 correct? 25 A. Yes. 0014 1 Q. And then on Page 104? 2 A. Yes. 3 Q. Do you know what the 4 significance was of stickying those? 5 A. In all of these cases -- and 6 there are the pink stickies as well in some of 7 the other documents -- I was looking for help 8 with understanding the nature of the consent 9 process and policies in this case. 10 Q. You have another deposition of 11 Dr. Burkhardt that was sent here, apparently. 12 And this has a couple of additional stickies on 13 it on Page 81 -- 14 A. Yes. 15 Q. -- Line 21 and on Page 82. 16 A. Yes. I should say sometimes the 17 placement of those stickers does not 18 necessarily correspond to a particular line I'm 19 interested in. I'm just reminding myself of a 20 page to look at. 21 Q. All right. You have 22 Mr. Sullivan's deposition. And you have 23 stickied, with your pink sticky here, Page 57? 24 A. Correct. 25 Q. What was the relevance of that 0015 1 sticky? 2 A. In this instance, there was 3 discussion of what the patient consented to. 4 And I guess that was the -- well, that was -- 5 that must have been the reason that I was 6 interested in that passage. 7 Q. And you stickied in particular 8 the portion where Mr. Sullivan said, quote, I 9 consented to the ablation, yes; is that 10 correct? 11 A. That's roughly where the sticker 12 is, yes. 13 Q. I mean, the question and answer 14 above -- 15 A. Correct. Yes. Yes. 16 Q. -- where it's 23 where the 17 question is, "He has documented in his record 18 that he discussed with you the risks, benefits 19 and alternatives of the procedure and you 20 consented to the procedure; is that true?" 21 And the answer was, "I consented 22 to the ablation, yes." 23 A. Yes. 24 Q. Then there's a question and 25 answer where the question was, "So you agree 0016 1 that he discussed with you the risks, benefits 2 and alternatives and you consented to the 3 procedure?" 4 And the answer was, "To the 5 ablation, yes," correct? 6 A. Yes. I was interested in the -- 7 in the way that he expressed himself in that 8 answer. 9 Q. Then we have Dr. Kanj. And you 10 stickied Page 63 at the top, correct? 11 A. Yes. 12 Q. And, actually, Page 75 at the 13 top, correct? 14 A. Yes. 15 Q. And Page 104; is that correct? 16 A. Correct. 17 Q. Do you believe that was all, 18 again, relative to the issue of the consenting 19 process? 20 A. Well, that's what I was looking 21 for when I put those stickies in. Generally, 22 unless there might have been something else. 23 But, generally, that's what I was interested 24 in. 25 Q. And then you have Dr. Cummings' 0017 1 deposition, and you stickied Page 42, correct? 2 A. Yes. 3 Q. And also Page 13, actually. 4 It's backwards. 5 A. Yes. 6 Q. There is, in this document, a 7 printed LexisNexis document as to the Ohio 8 Revised Section 2317.54. 9 Were you sent this by 10 Mr. Kulwicki? 11 A. Yes. 12 - - - 13 (Whereupon, Exhibit D is marked 14 for identification.) 15 - - - 16 BY MS. CARULAS: 17 Q. We have marked this as 18 Exhibit D. 19 A. All right. 20 Q. I assume prior to Mr. Kulwicki 21 sending you this, you had never reviewed or 22 been familiar with 2317.54; is that correct? 23 A. That is correct. 24 Q. You have here the policy and 25 procedure of the Cleveland Clinic that was in 0018 1 existence at the time, which is a four-page 2 document? 3 A. Yes. 4 Q. And you stickied Page 2 next to 5 the portion that says, "Written informed 6 consent forms signed by patients are not 7 utilized at the Cleveland Clinic unless 8 specifically required by law"? 9 A. Yes. 10 Q. You have the deposition of 11 Dr. Natale, but there is nothing stickied, but 12 you have a dog-ear, right? 13 A. I'm not sure the dog-ear is 14 significant. It might be where I stopped 15 reading at one point and didn't de-dog-ear it. 16 Q. Was there anything in 17 Dr. Natale's deposition to you that was, as you 18 sit here today, of significance? 19 A. I will just take a moment, if I 20 may? 21 Q. Sure. 22 A. No. This was a matter of 23 interest, general interest, in the procedure. 24 Q. Then we have another copy of 25 Dr. Kanj. We have a CV of Dr. Kanj; a CV of 0019 1 Dr. Burkhardt. A copy of Responses to Second 2 Request for Admissions. 3 Then you have in here what looks 4 like three different copies of an article where 5 the lead author is Dr. Di Biase, D-i capital 6 B-i-a-s-e, entitled, "Remote Magnetic 7 Navigation," correct? 8 A. Yes. 9 Q. Did you read that article? 10 A. I read one of the copies. 11 Q. Okay. 12 A. I kept them all. 13 Q. And there is some dark 14 highlighting sections on this document of what 15 was sent to you on all three copies. 16 A. Those are not my highlights. 17 Q. They were highlights that 18 existed before you received -- 19 A. Yes, ma'am. 20 Q. -- received it? 21 A. Yes. 22 MS. CARULAS: And I'll just mark 23 one of the copies as Exhibit E. Okay? 24 THE WITNESS: Yes. 25 - - - 0020 1 (Whereupon, Exhibit E is marked 2 for identification.) 3 - - - 4 BY MS. CARULAS: 5 Q. Then there is some additional 6 highlighting on here in green. 7 Is that yours? 8 A. I believe that's mine. 9 Q. I mean, is there any 10 significance to what you highlighted or is it 11 just to help you? 12 A. No. Just trying to keep track 13 of names and facts. 14 Q. And then there are some attached 15 records here. You highlighted the section -- 16 A. Yes. 17 Q. -- on the procedural sedation 18 record that does mention informed consent, 19 correct? 20 A. This is the document in which 21 the -- which the physician has initialed as 22 certifying that there was informed consent. 23 Q. Do you know whose these initials 24 were? 25 A. I don't think I was ever able to 0021 1 decipher those initials. But it looks like 2 Kanj. 3 Q. And did you see from his 4 testimony that that was -- do you recall his 5 testifying to that? 6 A. This was -- I don't recall him 7 testifying to that. But I will take it that he 8 did. 9 Q. All right. Then just for, 10 again, housekeeping purposes, you were sent a 11 copy of the Heart Rhythm Society Expert 12 Consensus paper? 13 A. Yes. 14 Q. Did you read it? 15 A. That paper I believe I scanned 16 to persuade myself that I was not an expert on 17 the subject of that paper. 18 Q. Fair enough. So it really is of 19 no significance -- 20 A. No. 21 Q. -- to you in this? 22 I assume before Mr. Kulwicki 23 sending this to you, you would have never -- 24 A. That's correct. 25 Q. -- had an opportunity to look at 0022 1 this? 2 A. I never had an opportunity to 3 look at that; that's correct. 4 Q. One thing I didn't give you in 5 my guidance ahead of time. But try, if you 6 can, to wait -- I'll try to do the same -- wait 7 until I finish, so we're not talking at the 8 same time and driving her crazy. Okay? 9 A. I always feel sorry for the 10 court reporter, because like many people, I 11 have a tendency to talk over the other person. 12 Q. We also have here a paper on the 13 NaviStar ThermoCool catheter. And this was 14 provided to you by Mr. Kulwicki as well, I 15 assume? 16 A. Yes, it was. 17 Q. It's a document marked from 18 Pages 30 through 63? 19 A. Yes, it is. 20 Q. Was that labeled like that 21 before you received it? 22 A. Yes, it was. 23 Q. Did you read it? 24 A. I scanned it. I did not study 25 it. It's not my area. 0023 1 Q. So you're not qualified to even 2 understand what it's saying; is that -- 3 A. No, ma'am. 4 Q. -- true? Okay. 5 Then we have the American 6 College of Cardiology, American Heart 7 Association Practice Guidelines. 8 Again, I assume you would have 9 never seen this prior to Mr. Kulwicki sending 10 it to you? 11 A. As far as I know, I didn't see 12 it before he sent it to me. 13 Q. You are not an expert in the 14 subject of electrophysiology to be able to 15 comment on these? 16 A. I am not. 17 Q. We have another copy of the 18 Heart Rhythm Society Guidelines. 19 Another copy of Stacy Poe's 20 deposition. 21 Looks like you were provided 22 with a copy of some of the materials that were 23 on the Cleveland Clinic Web site at the time? 24 A. Yes. 25 Q. And you reviewed that? 0024 1 A. Yes. 2 MS. CARULAS: We'll mark that as 3 Exhibit F. 4 - - - 5 (Whereupon, Exhibit F is marked 6 for identification.) 7 - - - 8 BY MS. CARULAS: 9 Q. There is some highlighting in 10 yellow. 11 Is that your highlighting? 12 A. I believe it is. Can I look at 13 this just to verify? 14 Q. Absolutely. 15 A. I have to say I don't remember 16 that this is my highlighting, but it might be. 17 I believe it probably is. Nothing else I 18 received was highlighted in any color. So it 19 probably is. 20 Q. All right. And the section that 21 was highlighted is the statement there, "Are 22 there any risks?" And it says, "The pulmonary 23 vein antrum isolation procedure is generally 24 very safe. However, as with any invasive 25 procedure, there are risks to ablation." 0025 1 A. That's what it says. 2 Q. Then you have a variety of -- 3 well, let's see what you have. 4 So you have, it looks like, 5 Dr. Burkhardt's record -- 6 A. Yes. 7 Q. -- that's in the form of a 8 letter to Dr. Makino, dated August 17th, 2006, 9 correct? 10 A. Correct. 11 Q. And you're aware of his 12 documentation in there that he did discuss the 13 procedure in detail and discussed the risks, 14 benefits and alternatives to Mr. Sullivan? 15 A. That's what he says in the 16 letter. 17 Q. Then he documented that, "He 18 consents to the procedure and wishes to 19 proceed," correct? 20 A. That's what the letter says. 21 Q. We're going to get into it in 22 great detail -- 23 A. Yeah. 24 Q. -- but you are not questioning 25 Dr. Burkhardt's integrity in putting this in 0026 1 the note, are you? 2 A. I'm not questioning the 3 integrity of anybody in this case, or the 4 institution. 5 Q. You're not disputing from 6 Dr. Burkhardt's statement that he did have a 7 discussion with him? I mean, you're not 8 disputing that? 9 A. I'm not disputing it. If he 10 says he had a discussion, then I will take him 11 at his word. 12 Q. Now, then we have 13 Dr. Burkhardt's -- a lot of the technical 14 records here from the procedure at the 15 Cleveland Clinic, which is in your file, but I 16 assume, again, you're not competent to 17 interpret those? 18 A. That's correct. 19 Q. Then you have the deposition of 20 Debbie Sullivan, correct? 21 A. Yes. 22 Q. And it doesn't look like you 23 stickied or dog-eared any of that, correct? 24 A. Correct. 25 Q. Then you have a binder here of 0027 1 some records. And I want to make sure I know 2 what all of these are. 3 So it looks like initially, 4 there are some records of Dr. Makino, do you 5 think? Or do you know what these are? Maybe 6 you can take a look. 7 A. I'll have to remind myself. 8 Q. Sure (handing). 9 A. So this -- these are office 10 notes from Dr. Makino. Yeah, they're all from 11 the file of Dr. Makino in Hawaii -- 12 Q. Did you read -- 13 A. -- so it appears. I read these 14 so I could get a larger understanding of what 15 happened in Hawaii. 16 Q. Did those come with the initial 17 stack or did you just receive those recently? 18 A. Oh, these came with the initial 19 stack. Certainly, it wasn't recent. It was 20 some time ago. 21 Q. Was there anything significant 22 to Dr. Makino's records to what you have to 23 offer in this case? 24 A. Well, and perhaps we'll talk 25 about this some more, it wasn't clear to me 0028 1 that Dr. Makino's conversations with the 2 Sullivans were exactly the same -- was the same 3 information as the Sullivans got in Cleveland. 4 So that leads to a larger concern that we can 5 talk about. 6 Q. All right. So then you have the 7 records of Dr. Shen, correct? 8 A. Yes. 9 Q. Who is Dr. Shen, do you recall? 10 A. I don't recall. He was some -- 11 was he a consultant? Was he a consultant in 12 Hawaii? I don't remember. 13 Q. Okay. 14 A. Right. He was one of the other 15 physicians in -- in Hawaii who takes care of 16 Mr. Sullivan, I gather. 17 Q. Were his records of any 18 significance to your opinions? 19 A. I don't believe so, other than 20 just giving me the general lay of the land. 21 Q. Then you have some records of 22 Dr. Hong. 23 Do you remember who Dr. Hong 24 was? 25 A. Another caregiver in Hawaii, as 0029 1 I recall, for Mr. Sullivan. 2 Q. Do you recall if there was any 3 significance to Dr. Hong's records? 4 A. No. 5 Q. No, you don't, or there weren't? 6 A. There was no -- I don't recall 7 any significance to those records for me. 8 Q. It looks like we have a loose 9 page of -- Pages 19 and 20 of Dr. Cummings' CV. 10 A. Yes. 11 Q. And then some other clinical 12 notes, which I assume have no significance to 13 your -- 14 A. Can I just look for a moment? 15 Q. Sure. 16 A. And there's an article here, if 17 you want to note it. 18 Q. Oh, yes. I didn't see that. 19 So then you have mixed in with 20 some records, additional clinical records. 21 Then there is an article where the lead author 22 is Patel, P-a-t-e-l, "Long-term functional and 23 neurocognitive recovery"; is that correct? 24 A. Yes. 25 Q. Do you believe then this 0030 1 encompasses the entirety of what you've 2 reviewed prior to authoring your report -- 3 A. I do. 4 Q. -- or for your opinions in this 5 case? 6 A. I do. 7 Q. Have you reviewed any other 8 literature to support your opinions in this 9 case? 10 A. I have not reviewed any of the 11 literature directly as a result of my 12 involvement in this case. I'm always reading 13 the literature. And this just happens to be 14 one of my interests, is the ethics of 15 innovative surgery or surgical research. 16 Q. Is there any literature that you 17 are specifically relying on for the opinions 18 you propose to give in this case? 19 A. There's no specific item that 20 I'm relying on. I'm relying on reading over 21 30-plus years in the field of medical ethics. 22 Q. But as far as quoting any 23 particular, this article supports your opinion 24 in this case -- 25 A. I'm not -- 0031 1 Q. -- you don't have a specific 2 article that you are so citing? 3 A. No. 4 Q. Now, can you give me an idea, 5 sir, as to prior to authoring your report to 6 Mr. Kulwicki -- and your report is dated 7 January 12th, 2011 -- 8 A. It's not. 9 Q. Do you have a different report? 10 A. What I have, I have January 7th. 11 Q. Okay. Let me see that. 12 MR. KULWICKI: I think, Anna, 13 for purposes of the record, I think what 14 happened is, they're exactly the same. 15 Dr. Moreno, because we were up against a 16 deadline, had e-mailed the unsigned 17 report, and I forwarded that to you. 18 THE WITNESS: That's right. 19 MR. KULWICKI: And then you put 20 it onto your letterhead and sent it again 21 with a new date, but everything else was 22 the same. 23 MS. CARULAS: Okay. 24 MR. KULWICKI: Just so you know. 25 What did you mark those, by the 0032 1 way? 2 MS. CARULAS: So this one is 3 marked Exhibit G. 4 - - - 5 (Whereupon, Exhibit G is marked 6 for identification.) 7 - - - 8 MS. CARULAS: I'll just take a 9 look, if I can. 10 THE WITNESS: Sure. 11 (Pause) 12 BY MS. CARULAS: 13 Q. Now, prior to this report, which 14 apparently is on letterhead dated January 7th 15 and was sent with your -- is this Washington, 16 D.C. address at your home? 17 A. Yes. 18 Q. That was e-mailed. 19 Other than these two forms, have 20 you authored any other reports or summaries in 21 this case? 22 A. No, I have not. 23 Q. Did you, prior to sending this 24 report, send any drafts at all or any initial 25 versions of it? 0033 1 A. I don't recall if I did. I 2 might have done so. I'm not remembering now if 3 I did. 4 Q. All right. Was that something 5 you would have a copy of, an initial draft? 6 A. I overwrite routinely these 7 things. 8 Q. Did you ever send an initial 9 draft to Mr. Kulwicki? 10 A. I might have done. I don't 11 remember it. We might have exchanged 12 conversation about an initial draft. I just 13 don't remember. 14 Q. Do you recall anything that was 15 changed between an initial draft and your final 16 report in this case? 17 A. Well, nothing substantive was 18 changed. As I thought more about the case, I'm 19 sure I added statements. So in that sense, 20 there was change. 21 Q. So when you first wrote your 22 report -- and do you know when it first was 23 that you sent a report to Mr. Kulwicki? 24 A. Well, all I know is these 25 particular dates. 0034 1 Q. Okay. 2 A. I would have been thinking about 3 it in December and might have jotted some 4 thoughts down in December last year. 5 Q. Then you say you spoke with 6 Mr. Kulwicki? 7 A. I might have done. I don't 8 remember. 9 Q. And you say you know that 10 certain things were added? 11 A. Right. Well, as one starts to 12 draft a statement, one thinks some more and 13 adds some more ideas. 14 Q. What were some of the more ideas 15 that one came to as one thought through it? 16 A. Well-put. Gee, unfortunately, I 17 don't specifically recall what might have come 18 later. 19 It's possible, because I was -- 20 well, this would make sense. I was really 21 focusing on the clinical side of the case, what 22 we would call clinical ethics of the informed 23 consent. 24 I think I then started thinking 25 more about the medical registry aspect. And so 0035 1 probably -- probably that ninth item on the 2 registry was something that I would have 3 thought about after I thought about the 4 clinical ethics piece. 5 Q. Is that something, the registry 6 issue that was raised as a point of discussion, 7 raised by Mr. Kulwicki to you? 8 A. It was a question that came up 9 early. It might have been in the first 10 conversation we had on the telephone. I don't 11 remember. But it was a question that came up 12 between us. 13 Q. So the -- 14 A. I think that I raised the 15 question whether this was related to any 16 research study. 17 Q. Okay. 18 A. And then he responded by calling 19 my attention to the registry verbally and then 20 had the information in writing. 21 Q. But then when you first drafted 22 your report, you didn't have anything in there 23 about the registry, but then you subsequently 24 added that for the final report; is that your 25 recollection? 0036 1 A. Yes. Can I only note -- 2 Q. Sure. 3 A. Well, that is not exactly my 4 recollection. I'm sure I was thinking about 5 these issues in parallel. Then as I thought 6 about it some more, I decided it was time to 7 commit a statement to paper. 8 Also, can I point out that my 9 name is misspelled on the exhibit note. It's 10 M-o-r-e-n-o, not M-a-r-i-n-o. 11 Q. Oh. Well, we'll change all of 12 those. How about if we do all of that at the 13 end. 14 A. You don't take offense. 15 Q. No, no, no. We'll change all of 16 them. 17 A. It just might cause confusion 18 later for you. 19 Q. No, I appreciate that. We'll 20 change them all before we leave. 21 A. That's not a hard one. 22 Q. So back to, you believe that 23 when you initially encapsulated your opinions 24 into a report, that you did not have number 25 nine on there and then subsequently added that, 0037 1 true? 2 A. That's -- that's entirely 3 possible. Frankly, I was so astonished that 4 there was no consent form that was signed by 5 the patient, that that was where my first line 6 of thinking went and the implications of that. 7 And then I probably logically 8 went through adequacy of consent after that and 9 then the research question. 10 Q. And then this last issue about 11 the remote magnetic navigation, I assume you 12 have no expertise at all in remote magnetic 13 navigation? 14 A. I don't. But when I was reading 15 the papers, it looked as though that was 16 clearly thought to be a novel or innovative 17 procedure. 18 Q. And the papers were sent to you 19 about by Kulwicki, correct? 20 A. Yes, ma'am. 21 Q. So fair enough that Mr. Kulwicki 22 raised the issue of the remote magnetic 23 navigation to you as opposed to you raising it 24 to him? 25 A. I honestly don't remember the 0038 1 order in which, whether I raised the question 2 or he did. I don't remember that. 3 Q. Prior to this particular case, 4 were you familiar at all with remote magnetic 5 navigation used in pulmonary vein ablation 6 procedures? 7 A. Well, familiar may be a bit 8 generous. I've heard it discussed at meetings 9 as an example of a procedure. But I would not 10 say that I was familiar with it. I had heard 11 about it. 12 Q. Right. Now, what is your 13 experience in medical-legal matters? 14 A. Well, I've been an expert on a 15 number of legal cases since the late 1990s for 16 both sides, as it were. I've given testimony 17 in one court. And I've been deposed -- and I 18 don't keep records of this, but I would guess 19 that I've been deposed about 15 or 20 times. 20 Q. How many cases have you actually 21 reviewed for lawyers? 22 A. So it depends how one defines 23 review. A couple of times a year, a lawyer 24 might call me and ask to talk about something 25 on the phone or ask me to look at something. 0039 1 And, generally, that's as far as it goes. 2 And in a minority of instances, 3 a lawyer would retain me to look at more 4 documents. 5 Q. So on how many in a given year 6 is your opinion requested? 7 A. Oh, well, including these sort 8 of phone calls that don't amount to any 9 relationship, maybe three times a year. 10 Q. Now, the one case that you 11 testified in court, where was that? 12 A. That was in -- in Boston, in the 13 federal court. I'm not a lawyer, so my 14 knowledge of which court is which is a little 15 vague. But it's the really nice courthouse on 16 the water next to the big dig. 17 Q. Right. 18 A. And that was 1999, I believe. 19 Q. Who were you retained by in that 20 case? 21 A. I don't remember his name. It 22 was a lawyer in Rockville, Maryland. 23 Q. Who did the lawyer represent? 24 A. He and a number of other lawyers 25 represented the families of people who had 0040 1 claimed they had been used unethically in an -- 2 a human experiment in the 1950s at 3 Massachusetts General Hospital. 4 Q. And you testified on behalf of 5 the families. 6 What was the substance of your 7 testimony? 8 A. This was a fascinating case that 9 involved using ionizing radiation -- in the 10 news these days because of Japan -- to try to 11 destroy cancer cells, glioblastoma cells in the 12 brain. 13 And I had been a senior staff 14 member of a presidential advisory commission on 15 the use of ionizing radiation in human 16 experiments. And so I was there to testify 17 about the development of research ethics, 18 policies and government standards on ionizing 19 radiation in medicine. 20 Q. Now, you say then you've given 21 about 15 to 20 depositions otherwise, correct? 22 A. That is probably right. 23 Q. Have you ever given a deposition 24 in a case out of Ohio? 25 A. Yes. In fact, now that you 0041 1 mention it, it's a case that is cited here. 2 And if you ask me the name of the case, I won't 3 remember it. But this also had to do with an 4 informed consent problem in Ohio. And I did 5 notice that that case was cited in one of the 6 legal documents that I saw. 7 Q. Oh. What legal document did you 8 see? 9 A. I was afraid you would ask me 10 that. I think it might have been the one that 11 is a printout of the -- of the law in Ohio. 12 Q. Was it the Request for 13 Admissions, this (indicating)? 14 A. No, no. It was that printout of 15 the law, the Ohio statute on informed consent, 16 perhaps. 17 Q. Oh, I see. I marked that. 18 A. Yes, the LexisNexis. So I'm 19 going with memory here. This is a 1999 case. 20 This is in Stewart versus Cleveland Clinic. 21 And I believe that's a case in which I was an 22 expert. 23 Q. Who retained you in that case, 24 do you know? 25 A. I don't remember. Oh, it was 0042 1 the -- it was the plaintiff in that case. It 2 was the attorneys for Stewart. 3 Q. Do you recall what the issues 4 were? 5 A. They were informed consent 6 issues. And I don't remember in detail what 7 they were. 8 Q. Now, that would be your only 9 experience in Ohio? 10 A. As far as I could recall. 11 Q. Now, what are the other states 12 that you have been involved in giving 13 depositions in cases? 14 A. Well, let me do my best here. 15 That case that I mentioned from the late '90s 16 in which I testified involved New York and 17 Massachusetts. Cases in the District of 18 Columbia. I'm going to say there was a case in 19 Maryland. 20 This is scary when you get to be 21 this age and have to go through the memory 22 banks. 23 New Jersey. I think that might 24 be -- Nevada, I think, but that never became a 25 deposition. I think that might be it. 0043 1 Q. All right. Now -- 2 A. Oh, Florida. 3 Q. In all of these cases, were you 4 retained on behalf of the plaintiff? 5 A. In -- in at least one of the 6 recent cases that I remember, I was retained a 7 couple of years ago for the defense. And that 8 was a New Jersey case that involved a question 9 of whether a particular individual must have 10 been admitted to a compassionate use of 11 trial -- or to use a device that was in a 12 clinical trial, but admitted for what is known 13 as compassion of use. 14 Q. Did that go to a deposition? 15 A. It did not. 16 Q. You were asked to review it on 17 behalf of the defense. 18 Were you able to support the 19 defense side of the case? 20 A. I agreed with the defense in 21 that case. 22 Q. And all the other cases were on 23 behalf of the plaintiff? 24 A. I wouldn't say all. The 25 majority of them were on behalf of the 0044 1 plaintiff. 2 Q. Can you think of any other case 3 that was on behalf of the defense? 4 A. This -- so this never also got 5 to a deposition. There was a meeting that I 6 had maybe eight years ago, when I was still at 7 the University of Virginia. And if memory 8 serves, they were from Nevada. The question 9 there had to do with responsibility for the 10 so-called downwinders of ionizing radiation. 11 And as I recall, they were representatives of 12 the university. 13 So that's my recollection. 14 Q. All right. Any others you can 15 recall on behalf of the defense? 16 Were you able to support the 17 defendant's side on that case? 18 A. That never went further than a 19 conversation in my office. 20 Q. I see. Does that mean because 21 you were unable -- 22 A. I don't know why. 23 Q. You don't know? 24 A. I don't know why. 25 Q. Of these other cases, you state 0045 1 the majority were for the plaintiff. 2 A. Yes. 3 Q. Have your qualifications to give 4 testimony, to your knowledge, ever been raised 5 and you have been disqualified to testify? 6 A. I've been disqualified once on 7 the grounds that I'm not a medical doctor who 8 specialized in that area of medicine. 9 Q. Where was that case? 10 A. I believe that was Maryland. 11 Q. Do you remember the specifics of 12 the case? 13 A. It was a -- I don't. It was a 14 case that involved Kaiser Permanente, I 15 believe. But I do not remember the specifics 16 of that case. That was about 13 years ago. 17 Q. Do you remember the nature of 18 the type of medical procedure or issue that 19 was -- 20 A. I think that they were looking 21 for people in internal medicine, as I recall. 22 Q. Do you remember what the issue 23 was? 24 A. I don't. 25 Q. Do you remember the name of the 0046 1 the case? 2 A. I don't. 3 Q. Any other cases where you can 4 recall that it got to the point where you were 5 disqualified by the court? 6 A. No. 7 Q. Is it possible there were others 8 and you say, because only one went on to 9 trial -- 10 A. Yeah. 11 Q. -- that you just don't know the 12 details of it? If you know. 13 A. I don't know. I think that 14 would stick in my mind as -- because I find 15 it -- I find it interesting how one 16 distinguishes between the ethical issues and 17 the medical issues. 18 And I think I would probably -- 19 I would probably remember if I had been 20 disqualified from another one. 21 Q. Okay. 22 A. I should also add that I have 23 turned down cases or advised plaintiff 24 attorneys not to pursue cases. 25 MS. CARULAS: All right. I have 0047 1 a copy of your CV that was provided to 2 me. I'm trying to keep everything 3 separate here. 4 What are we up to, do you know? 5 THE COURT REPORTER: Exhibit H, 6 I think. 7 - - - 8 (Whereupon, Exhibit H is marked 9 for identification.) 10 - - - 11 BY MS. CARULAS: 12 Q. So I've marked your CV as 13 Exhibit H. And I'm not going to go through it 14 in great detail in the interest of time. 15 But it's my understanding that 16 your education is in the field of philosophy; 17 is that correct? 18 A. Yes, it is. 19 Q. Is it a master's in philosophy? 20 A. I didn't do that. I only got a 21 Ph.D. 22 Q. You did an undergrad in 23 philosophy -- 24 A. And psychology, yes. 25 Q. -- was your degree? 0048 1 A. I'm sorry. I did an 2 undergraduate degree in philosophy and 3 psychology. And my Ph.D. is in philosophy. 4 Q. In philosophy, all right. 5 You are not a medical doctor? 6 A. I'm not. 7 Q. You have no medical education or 8 training? 9 A. I have no formal medical 10 education or training. 11 Q. You do not hold any licensure in 12 a medical field, correct? 13 A. That is correct. 14 Q. And you do not hold any 15 licensure in any field, correct? 16 A. That's correct. 17 Q. You're not a lawyer, correct? 18 A. I am not. 19 Q. And you do not have an active 20 license to practice law? 21 A. No, I don't. 22 Q. I know I've read a few of your 23 publications. 24 A. Thank you. 25 Q. You're welcome. 0049 1 And I see that you describe 2 yourself in these publications as a layperson? 3 A. Yes, with respect to medicine. 4 Q. You do not hold yourself out as 5 a medical professional, correct? 6 A. I would not hold myself out as a 7 medical professional in the normal sense of the 8 term. 9 Q. Now, your employer is whom? 10 A. The University of Pennsylvania. 11 Q. Are you actually employed by the 12 medical school or by the undergraduate school? 13 A. So I have a somewhat unusual 14 position. I have an endowed share that tenures 15 me in both the Medical School and the School of 16 Arts and Sciences. 17 Q. But while you have an 18 appointment of sorts, you're actually an 19 employee of the undergraduate institute; is 20 that -- 21 A. No. I'm actually an employee of 22 the University of Pennsylvania. My tenure 23 homes are both the Medical School and the 24 School of Arts and Sciences. 25 Q. Okay. Now, you are not employed 0050 1 by the Hospital of the University of 2 Pennsylvania, correct? 3 A. That's correct. 4 Q. Do you have any type of 5 appointment at all at the Hospital of the 6 University of Pennsylvania? 7 A. I do not. 8 Q. And you've been here now at the 9 University of Pennsylvania for how long? 10 A. Since January 2007. 11 Q. Have you ever, at any point in 12 time, been actually employed by a hospital or a 13 medical center as opposed to the university? 14 A. Well, at the University of 15 Virginia, I was -- my chair and my tenure were 16 in the medical school. I'm not sure what the 17 corporate description would be with respect to 18 my position. 19 At -- at the State University of 20 New York, Downstate Medical Center, I was a 21 professor. That medical center includes both a 22 medical school and a state hospital and a city 23 hospital. 24 Again, I'm not sure how you 25 would distinguish the responsibilities that one 0051 1 would have with respect to the medical school 2 or the hospital. 3 Q. Okay. 4 A. But that was a medical -- that 5 is a medical center. 6 Q. But you have technically always 7 been considered an employee of a university? 8 A. Yes. 9 Q. Now, I know you said you did not 10 recognize the name of the individual who is the 11 electrophysiology expert here at the University 12 of Pennsylvania? 13 A. I don't know the man. 14 Q. Can you name any of the 15 electrophysiologists that practice at the 16 Hospital of the University of Pennsylvania? 17 A. Not offhand. 18 Q. Dr. Callans, C-a-l-l-a-n-s, is 19 the expert involved in this case from an 20 electrophysiology perspective. 21 Prior to Mr. Kulwicki telling 22 you that he was involved in the case, I assume 23 you've never heard of Dr. Callans? 24 A. I don't remember hearing his 25 name before. 0052 1 Q. Have you ever heard of 2 Dr. Marchlinski, M-a-r-c-h-l-i-n-s-k-i? 3 A. No. 4 Q. So I take it you have no 5 interaction whatsoever with the 6 electrophysiology department at the Hospital of 7 the University of Pennsylvania? 8 A. Not so far as I recall. It may 9 be that I've attended a case conference where 10 there are people from the department who are 11 present. But nothing registers. 12 Q. As you sit here today, you 13 cannot say that you've ever participated in a 14 meeting with the electrophysiology department 15 at the Hospital of the University of 16 Pennsylvania? 17 A. That's correct. 18 Q. Have you ever interacted, to 19 your knowledge, with any of the other 20 cardiologists at the Hospital of the University 21 of Pennsylvania other than the specialists in 22 electrophysiology? 23 A. I'm sorry, can you rephrase 24 that? 25 Q. Sure. That was really garbled 0053 1 and long. I apologize. 2 The same question about just the 3 general department of cardiology. Do you have 4 a recollection of ever interacting with anyone, 5 even a non-specialist, not an 6 electrophysiologist, at the Hospital of the 7 University of Pennsylvania? 8 A. I do not. 9 Q. As far as the medical issues in 10 this case, one of the issues here, of course, 11 is atrial fibrillation. 12 A. Yes. 13 Q. Would it be fair to say that you 14 have no expertise, beyond that of a layperson, 15 to share with the jury on the subject of atrial 16 fibrillation? 17 A. That's correct. 18 Q. And as far as the treatment for 19 atrial fibrillation, you have no expertise 20 beyond that of a layperson? 21 A. That's correct. 22 Q. As far as the risks of atrial 23 fibrillation or the risks of any alternative 24 treatments for atrial fibrillation, you have no 25 expertise beyond that of the average layperson 0054 1 to share with the jury? 2 A. That's correct. 3 Q. And as far as the actual 4 catheter ablation procedure that was performed 5 in this case, the risks of that, any of the 6 details of that procedure, the instruments 7 used, any of that, you have no expertise beyond 8 that of a layperson to share with the jury? 9 A. Yes. 10 Q. Have you, sir, ever personally 11 been responsible to have an informed consent 12 discussion with a patient who underwent a 13 pulmonary vein antrum isolation procedure? 14 A. No. 15 Q. Have you ever personally had the 16 responsibility to give an informed consent 17 discussion with a patient to undergo any type 18 of electrophysiology procedure? 19 A. No, I have not. 20 Q. Have you ever sat in on a 21 discussion that an electrophysiology specialist 22 here at the Hospital of the University of 23 Pennsylvania had with their patients? 24 A. No. 25 Q. Have you ever, at any of the 0055 1 medical schools where you have worked over your 2 career, ever sat in on an informed consent 3 discussion between the electrophysiologist and 4 the patient? 5 A. I don't recall that I have. 6 Q. Have you ever been involved in 7 drafting a consent form for a pulmonary vein 8 antrum isolation procedure? 9 A. No. 10 Q. Would you feel competent and 11 qualified to put together a specific consent 12 form on the issues of a pulmonary vein antrum 13 isolation procedure? 14 A. On the technical medical issues? 15 Q. Yes. 16 A. No. Let me qualify that. I and 17 other people who do bioethics often have a role 18 in reviewing draft consent forms and helping 19 colleagues in medicine think about how to 20 express risks, benefits, alternatives in the 21 consent form. 22 But, of course, with respect to 23 medical questions of a technical nature, I'm 24 dependent on what they tell me. And then we 25 worry about how to describe it. 0056 1 Q. All right. You've mentioned 2 that you've never participated in putting 3 together a consent form for this type of 4 procedure that was used in this case? 5 A. As far as I remember. 6 Q. Have you ever assisted -- I 7 guess I know the answer already, because you 8 don't think you have ever interacted with the 9 cardiology department at the Hospital of the 10 University of Pennsylvania. 11 I assume you have never 12 participated in putting together any type of 13 consent form at the Hospital of the University 14 of Pennsylvania? 15 A. Not at Penn, no. 16 Q. In prior years, have you been 17 involved in that? 18 A. Yes. 19 Q. Whereabouts? 20 A. I would have been involved at 21 Downstate Medical Center in New York. And if 22 memory serves, at the University of Virginia. 23 Q. You were at -- I'm sorry, it's 24 Downstate? 25 A. It's the State University of New 0057 1 York, often called -- 2 Q. SUNY? 3 A. -- Downstate Medical Center, 4 SUNY. 5 Q. Now, there's Dr. Levine who's 6 testifying in this case. I think he's at SUNY. 7 Do you know him? 8 A. Can you tell me the first name? 9 Q. Steven, S-t-e-v-e-n. 10 A. It -- it's not unfamiliar. But 11 I know a lot of -- a few Steve Levines, I 12 think, and so I may be echoing the name. 13 Q. You had no knowledge he was in 14 the case. So I assume you had no knowledge 15 and -- 16 A. No, ma'am. I didn't know he was 17 in the case. And I have no idea what he would 18 say. 19 Q. I'm sorry, you were at Downstate 20 SUNY; is that -- 21 A. Yes. 22 Q. What years? 23 A. 1989 to 1998. 24 Q. Do you recall what type of 25 consent forms you helped put together? 0058 1 A. I don't. Specifically, there 2 were -- I was a member of the IRB for several 3 years. And it was fairly common for us to go 4 through consent forms and make suggestions and 5 require some changes. And that would have been 6 the primary setting in which I would have been 7 involved in helping draft consent forms. 8 Q. All right. 9 A. Or editing consent forms, 10 revising forms. 11 Q. The primary folks putting those 12 together, I would assume, would be the doctors 13 and the lawyers? 14 A. Well, one hopes not the lawyers, 15 so much as the people -- the investigators, the 16 medical investigators. 17 Q. They're the primary ones, the 18 doctor, involved in putting those together? 19 A. In general, yes. 20 Q. Then you might put a touch or 21 add something to it? 22 A. Well, that might be a bit too 23 minimal. There might have been situations in 24 which we asked for significant revision of the 25 consent form, depending on how confident we 0059 1 were that the issues that were relevant to the 2 patients or patient subjects were being 3 addressed in that draft. 4 Q. Can you, as you sit here today, 5 recall any of the types of procedures you gave 6 input on regarding a consent form? 7 A. You know, it was a -- there was 8 only one IRB for Downstate. And the -- so we 9 would have seen pretty much -- we would have 10 seen everything in every department. At least 11 we should have. Two areas that were very 12 prominent in my recollection were HIV AIDS and 13 oncology. Particularly in gynecologic 14 oncology, there was a lot of work being done at 15 that time. 16 Q. Can you recall ever 17 participating or giving input regarding a 18 surgical procedure? 19 A. I'm confident that I did. I 20 don't recall specifics right now, but I had a 21 substantial role in talking to physicians at 22 Downstate. 23 Q. Ever recall, at Downstate, 24 interacting at all or putting together a 25 consent form regarding an electrophysiology 0060 1 procedure? 2 A. I don't recall that. 3 Q. And then you say, if memory 4 serves you, you might have been involved in 5 this process at UVA? 6 A. Yes. Again, now at UVA, I was 7 not on the IRB. I was a consultant to the IRB. 8 And there would be telephone conversations 9 trying to sort out details of consent forms, 10 what should be disclosed and what shouldn't be. 11 I was also on the ethics 12 consultation service for the hospital. And 13 questions about consent forms undoubtedly came 14 up. I can't recall a particular one at this 15 time. 16 Q. And you were at UVA when? 17 A. From 1998 to 2006. 18 Q. Do you recall ever being 19 involved in giving input on a consent form at 20 UVA regarding an electrophysiology procedure? 21 A. I don't. 22 Q. You've already told me you are 23 not a lawyer, correct? 24 A. Yes. 25 Q. So, obviously, you are not a 0061 1 judge, true? 2 A. Not yet. 3 Q. And so you would agree that you 4 are not qualified to give a legal opinion? 5 A. That's correct. 6 Q. Now, prior to authoring your 7 report in this case dated -- 8 A. January. 9 Q. -- January of 2011, Mr. Kulwicki 10 had provided you with what we have marked as 11 Exhibit D, which is portions of an Ohio revised 12 code provision, correct? 13 A. Yes. 14 Q. Prior to that, were you provided 15 with any other summary or description of what 16 Ohio law says regarding informed consent? 17 A. No. Now, it's possible I was 18 provided with something during that Stewart 19 case, if that is, in fact, the case that I 20 participated in 12 years ago. But I don't -- I 21 certainly did not consciously rely on anything 22 about Ohio law. 23 Q. So for your opinions in this 24 case, did you take into consideration Ohio law? 25 A. Well, no. I'm not a lawyer. 0062 1 I'm not even sure I know how to apply or 2 interpret Ohio law. So I was really interested 3 in the ethical standards. 4 Q. All right. Now, you would 5 agree, sir, that there can be indeed a 6 difference between -- 7 A. Law and ethics? 8 Q. -- law and ethics? Thank you. 9 A. Yes, there can be. 10 Q. And you've discussed, I know, 11 from some of your readings, that you consider 12 yourself a philosopher, correct? 13 A. My colleagues in philosophy 14 would probably blanch at that statement. But I 15 consider myself still to be a philosopher by 16 discipline. 17 Q. As a philosopher, how you've 18 described it in some of your publications is, 19 you talk about ethics and moral codes? 20 A. Yes, ma'am. 21 Q. And some of your publications 22 was that ethics and moral codes really begin in 23 childhood and are brought to us by our parents, 24 correct? 25 A. Well, that's a -- that's a sort 0063 1 of moral development view. I guess I prefer to 2 say that our ethical and moral codes are part 3 of the growth of development of civilization. 4 And that, as individuals, we -- as the old 5 saying used to go, we learn about then what our 6 mothers need. 7 Q. I think that's what I had read. 8 Okay. 9 And you would agree that the 10 usual of ethics and morals is, by nature, 11 subjective? 12 A. No, I wouldn't. 13 Q. Okay. 14 A. I think there are universal 15 principles of ethics. I would not want to call 16 them subjective insofar as that suggests that 17 they're somehow relative. 18 I do agree that those principles 19 must require interpretation. But I don't 20 believe that they're subjective. 21 Q. In a given situation, different 22 people can interpret -- 23 A. The principles in different 24 ways. 25 Q. Okay. 0064 1 A. And that's why it's especially 2 important to have professional organizations 3 and conversations with professionals about what 4 the proper interpretation and application of a 5 principle should be. 6 Q. Now, when we talk about law on 7 the one hand and ethics on the other, we know 8 under the law, ultimately a judge can determine 9 or does determine what is legal or not legal. 10 True? 11 A. That's my understanding. 12 Q. And sometimes there can be 13 certain things that are legal in some states, 14 yet different individuals would have differing 15 opinions as to whether or not the law is 16 ethical? 17 MR. KULWICKI: Object. You can 18 answer if you understand. 19 A. I'm going to ask you to repeat 20 that one. 21 BY MS. CARULAS: 22 Q. Sure. There are certain laws on 23 the books that are there from one state to 24 another. For instance, capital punishment, 25 right? 0065 1 A. Yes, ma'am. 2 Q. In some states, capital 3 punishment is legal. In other states, it's not 4 legal, correct? 5 A. That's correct. 6 Q. And it's essentially governed by 7 state law, true? 8 A. As I understand it. Except for 9 the constitutional question, cruel and unusual 10 punishment, but yes. 11 Q. Now, while capital punishment is 12 legal in some states, laypeople -- not judges, 13 lay people -- looking at that, some will 14 believe capital punishment is ethical and some 15 disagree and believe it's not ethical, true? 16 A. Well, I guess I'd qualify it. 17 It looks to me as though judges disagree as 18 well, even within a single state, at least with 19 respect to the procedures required by the 20 constitution for -- for capital punishment. 21 So judges do disagree. And one 22 of the ways that the law progresses organically 23 is through colloquies over the generations 24 among judges, lawyers, laypeople and experts. 25 Q. From an ethical standpoint, 0066 1 there can be different interpretations of 2 whether or not a given situation is ethical or 3 not ethical? 4 A. So that's not so obvious to me. 5 Q. Okay. 6 A. Very often, what are thought to 7 be ethical disagreements are really 8 disagreements about facts. 9 And my experience in the medical 10 world, there are very few disagreements about 11 ethics. When you sit down with people and 12 start exploring a case, what you often find out 13 is that there has been -- there is a failure to 14 disagree on the basic facts. And that once the 15 facts are a matter of agreement, that you can 16 find ways to achieve that moral consensus. 17 Q. I would assume that part of your 18 job as a professor is, you have panel 19 discussions and debates on given subjects? 20 A. Actually, that's not the way 21 that most people in bioethics proceed. That's 22 a popular way to proceed, to have the pros and 23 the cons in a newspaper or a magazine article 24 about ethics. 25 But people who teach 0067 1 professional ethics don't like that debating 2 format. And the reason is that it seems to 3 create an adversarial relationship. 4 Q. Have you ever moderated panel 5 discussions on ethical issues? 6 A. Countless times. 7 Q. What is the purpose of doing 8 that? 9 A. It's to share information, share 10 views, have an exchange. Sometimes people 11 change their minds about things. Sometimes 12 they don't. 13 But it would be reductive to 14 call it a debate, insofar as a debate implies 15 that people come in with fixed positions that 16 they're not going to change no matter what. 17 You require a level of openness 18 that's not the case in an adversarial 19 situation. 20 Q. I see. But nevertheless, issues 21 are openly discussed and people can change 22 their mind or vacillate as far as their 23 interpretations as time goes on? 24 A. People, one hopes, do change 25 their minds as time goes on. Otherwise, 0068 1 there's not a good reason to have that 2 discussion. 3 Q. Now, you say that you did not 4 use Ohio law as a framework for your opinions 5 that you authored in your January of 2011 6 report, true? 7 A. To the best of my recollection. 8 Q. And I just want to make sure I'm 9 understanding. I apologize if I'm repeating. 10 A. That's okay. 11 Q. Did Mr. Kulwicki ever tell you 12 whether or not Ohio law requires a written 13 informed consent document? 14 A. Actually -- 15 MR. KULWICKI: Objection. 16 You can answer. 17 A. (Continuing) -- I'm sure 18 Mr. Kulwicki must have thought I was out of my 19 mind the first time he called me. Because I 20 remember three times asking him, well, what 21 about the consent form. And he kept saying, 22 there was no written consent form signed by the 23 patient, which I found absolutely amazing. 24 And -- and I guess it was either 25 in that conversation or are when he sent me 0069 1 the -- the statute that I noted that there was 2 no requirement in the law. 3 BY MS. CARULAS: 4 Q. Okay. So you do -- 5 A. That's what it appears to be. 6 I have to say, as a non-lawyer 7 looking at it, I don't know how you would 8 satisfy the spirit of that statute without 9 having a patient sign the form. But I'm not 10 going to put myself in the position of being a 11 lawyer interpreting it. 12 Q. You obviously will follow the 13 law that the judge sets forth in this case? 14 A. The judge is the -- is the 15 authority -- 16 Q. Okay. 17 A. -- as far as the power of the 18 state is concerned. 19 Q. All right. Now, I want you to 20 assume this, okay? And let's talk. I want you 21 to assume that to succeed on their claim, the 22 plaintiff's claim, for lack of informed 23 consent, the plaintiff must establish that the 24 physician failed to disclose to the patient and 25 discuss the material risks and dangers 0070 1 inherently and potentially involved with 2 respect to the proposed therapy, if any. Okay? 3 And then there's two other 4 elements. But did you understand what I just 5 said to you? Do you want me to read it again? 6 A. Yes, I think I understand. I 7 mean, you want me to reach a conclusion about 8 what the law says. 9 Q. No. I'm not going to ask you to 10 reach a conclusion about it. I want you to 11 assume that. Okay? 12 A. Well, all right. 13 Q. You're grimacing. What is your 14 problem with it? 15 A. Well, so whenever you set up a 16 hypothetical, you can ask -- in a friendly way, 17 you can ask the other person to assume almost 18 anything that has all kinds of implications. 19 I mean, my -- my -- my problem 20 is that the statute fails to do what I think a 21 reasonable person would think the statute would 22 do, which is to ensure that the individual has 23 given informed consent. 24 Q. Are you aware that actually the 25 Ohio Supreme Court has held that a written 0071 1 consent form is not a requirement for informed 2 consent? 3 Let me just ask, were you aware 4 that Mr. Kulwicki told you that? 5 MR. KULWICKI: Are you 6 suggesting that there's a ruling that 7 says that Ohio law says that informed 8 consent is not required in every single 9 context? 10 I mean, I think you're 11 misrepresenting the law. And that's not 12 appropriate. 13 MS. CARULAS: Let me strike that 14 and we'll start over. 15 A. Well, we have agreed before that 16 judges can disagree and the law advances. And 17 I would say, respectfully, that if anything 18 along the lines of what you described was the 19 conclusion of the Ohio Supreme Court, that the 20 Supreme Court needs to rethink that. 21 BY MS. CARULAS: 22 Q. Or if it was the Supreme Court 23 or any court -- 24 A. Any court. 25 Q. -- governing this, you think it 0072 1 needs to rethink it? 2 A. I think that needs to be 3 rethought. But I'm not sure -- again, I'm not 4 sure of the scope of -- what is the scope of 5 the statement you just made, but I'll take it. 6 Q. All right. In the context of 7 what the law is, you would agree that you are 8 not qualified -- I think we've been through 9 this -- but you are not qualified to say what 10 the material risks and dangers are of this 11 procedure that Dr. Burkhardt, who does this 12 procedure, or Dr. Callans, who does this 13 procedure here at the Hospital of the 14 University of Pennsylvania, you're not 15 qualified to say what risks and dangers an 16 electrophysiologist should tell the patient, 17 true? 18 A. I am not qualified to describe 19 those risks from a technical point of view. I 20 would have to be dependent on the information 21 they gave me, if I were helping with the 22 consent form. 23 Q. So you obviously, as far as the 24 details of what should have been discussed with 25 Mr. Sullivan in this case, you defer to an 0073 1 electrophysiologist on that? 2 MR. KULWICKI: Objection. 3 A. I'm sorry, can you say that 4 again? 5 BY MS. CARULAS: 6 Q. Sure. The details of the 7 procedure, the details of the risks, the 8 details of the indications for the procedure, 9 this procedure that Mr. Sullivan underwent, you 10 would defer to an electrophysiologist on that? 11 MR. KULWICKI: Objection. 12 You can answer. 13 A. I'm sorry, I'm not trying to be 14 argumentative. 15 BY MS. CARULAS: 16 Q. Yes. 17 A. "The details." Can you explain 18 what you mean by "the details"? 19 Q. Yes. We've been through it. 20 You would not even, in your 21 wildest imagination, sit down with a patient 22 and start to tell them what a pulmonary vein 23 antrum isolation procedure would be, how it's 24 performed, what device -- 25 A. I'm comfortable with agreeing 0074 1 with you in that formulation, yes. 2 Q. You would not, in your wildest 3 imagination, tell them there is this risk or 4 that risk and the percentage of the risk 5 because you don't know that. You're not a 6 medical doctor and you're certainly not an 7 electrophysiologist, true? 8 A. That's correct. I would be 9 interested in how that material is framed, both 10 written and non-written, how the discussion 11 proceeds. 12 But the technical literature, I 13 would not pretend to be able to convey. The 14 medical -- specifically technical medical 15 issues, I would not pretend to know in the 16 first -- in the person the way they would. 17 Q. And you are not qualified and do 18 not plan to say that Dr. Burkhardt's informed 19 consent discussion that he had with Shannon 20 Sullivan was inappropriate, true? 21 MR. KULWICKI: Objection. 22 You can answer. 23 A. "Inappropriate." I'm not sure 24 what you mean by "inappropriate." 25 BY MS. CARULAS: 0075 1 Q. Yes. You're not here -- I mean, 2 Mr. Kulwicki has already conceded this. You're 3 not here -- 4 A. I may not be prepared to concede 5 everything Mr. Kulwicki does. 6 MR. KULWICKI: Yes. I don't 7 know that I have conceded this. 8 Go ahead. 9 A. (Continuing) But in any case. 10 BY MS. CARULAS: 11 Q. As far as you are aware -- we've 12 looked at this -- that Dr. Burkhardt sat down 13 with Shannon Sullivan back on August 16th of 14 2006 and had a discussion with him about the 15 nature of the procedure and the risks and 16 benefits, correct? 17 A. I'm not claiming that there's 18 anything deceptive about any statements that 19 have been made by the people in -- who, I 20 presume, are operating in good faith in this 21 case. 22 Q. So I just want to leave here 23 today and make sure I understand. 24 You are not going to say David 25 Burkhardt was in any way inappropriate in -- 0076 1 well, I mean, you can't say whether or not his 2 -- and you don't plan to say whether or not his 3 interaction with Mr. Sullivan was reasonable or 4 not or met with acceptable standards of care 5 for an electrophysiologist? 6 MR. KULWICKI: Objection. 7 You can answer. 8 A. Well, I take him at his word. 9 If he said he did "X," I -- I take him at his 10 word. I don't think there is any intentional 11 deception on anybody's part. 12 BY MS. CARULAS: 13 Q. So assuming that the law is that 14 in order to prove informed consent, plaintiff 15 must prove that the physician -- who we know is 16 David Burkhardt in this case -- failed to 17 disclose to the patient and discuss the 18 material risks and dangers inherently and 19 potentially involved with respect to the 20 proposed therapy, if any, you cannot comment 21 one way or the other on that? You're taking 22 his word, correct? 23 A. Well, those are two different 24 questions. You asked me about the law. And 25 then at the end, you asked me about him, what 0077 1 he did. 2 I already said I'm not accusing 3 anybody of any deception. I do want to say 4 that, as written, that statute doesn't seem to 5 me to do what I think informed consent 6 requires, which is a signed consent form by the 7 patient. And I base that on 30 years of work 8 in this area. 9 Q. So you've already told me you 10 have no specific problem with David Burkhardt. 11 Your problem more is with the way Ohio law is 12 written as far as the requirements for informed 13 consent? 14 A. Ohio law as written and perhaps 15 as Ohio law as interpreted. 16 Q. Now, in looking at this case -- 17 and I'm going to object again to this because 18 your opinions essentially are as a layperson 19 here, but just to go forward with this -- there 20 is obviously evidence in the materials that 21 you've reviewed here that Mr. Sullivan was 22 aware that there were risks to this procedure, 23 correct? 24 MR. KULWICKI: Objection. 25 You can answer. 0078 1 A. Would you like to give me some 2 examples? I just -- that's a very broad 3 statement. 4 BY MS. CARULAS: 5 Q. Sure. Before I go into the 6 examples. 7 Are you aware of anything, in 8 all the materials you looked at here, that 9 Mr. Sullivan was aware that there were risks to 10 this procedure? 11 MR. KULWICKI: Well, you know, I 12 object because to ask what he was aware 13 of, you're asking him to convey what his 14 state of mind is. I mean, you can ask if 15 he's aware of testimony. 16 I just don't think that's an 17 appropriate question. I think that's a 18 very deceptive question. I think there's 19 a fair way you can ask it, though. 20 I mean, obviously, we all know 21 Burkhardt testified that he told him. 22 You can ask that. I mean, that's 23 obvious. 24 But to ask him what Sullivan 25 knew or what he was aware of, I don't 0079 1 know how he can -- that's just . . . 2 A. The problem is the word 3 awareness is so vexed. I could ask you if 4 you're aware of the wall behind you at this 5 moment. No, not until I called your attention 6 to it. 7 I mean, the sense of awareness 8 is really complex. 9 BY MS. CARULAS: 10 Q. Besides the documentation by 11 Dr. Burkhardt -- we have the documentation that 12 he advised Mr. Sullivan of the risks of the 13 procedure, correct? 14 A. We have his documentation that 15 he says that he did that. 16 Q. And you have read his deposition 17 where he testified that he did, indeed, as 18 documented in the note, have a detailed 19 discussion with Mr. Sullivan and that, in 20 particular, he told him there was a risk of 21 stroke to this procedure. 22 Did you read that? 23 A. That is -- I read it. And as I 24 recall, that's what was in his testimony. 25 Q. Again, you have no reason to 0080 1 question his integrity in his testimony? 2 A. I do not. 3 Q. Besides that documentation that 4 Mr. Sullivan was told there are risks to the 5 procedure, are you aware of any other 6 documentation in this case that would be some 7 evidence that Mr. Sullivan was told about 8 risks? 9 A. Well, I recall that there are 10 other people who claimed, perhaps in the second 11 person, that they were aware that -- or that 12 they believed that Mr. Sullivan was told of the 13 risks. 14 So there are numbers of 15 statements that assert that he was aware of 16 risks, had some sense of awareness. 17 Q. Right. We saw, and I went 18 through it a little bit ago, that there is a 19 Web site that Mr. Sullivan looked at, that 20 although it does not list out details, it does 21 say something to the effect, as with all 22 procedures, there are risks associated with 23 that. 24 You saw that, correct? 25 A. I did see that. I hope you're 0081 1 not suggesting that Cleveland Clinic is -- is 2 relying on a Web site, since we know what the 3 Web is like in this case. 4 Q. Right, no. And I don't think 5 anyone, any reasonable person, whether it's a 6 patient or a physician, can necessarily rely on 7 the Web. 8 Would you agree with that? 9 MR. KULWICKI: Objection. 10 A. Well, the problem is that if the 11 site is a representation by the organization, 12 then it would be reasonable for anybody to take 13 it as a statement that was made by the 14 organization. 15 BY MS. CARULAS: 16 Q. So it's certainly not the 17 informed consent discussion. That is, the 18 informed consent is a process between a 19 physician and a patient? 20 MR. KULWICKI: Objection. 21 Compound question. 22 A. So -- 23 BY MS. CARULAS: 24 Q. Let me start over. I want to 25 just keep this focused, if we can. Otherwise, 0082 1 we'll be here all day, and I have a plane to 2 catch. 3 MR. KULWICKI: Anna, you haven't 4 asked him a single question about his 5 opinions. I mean, you're so bent on 6 trying to ask everything but what a 7 medical ethicist does in this case and 8 what hospital standards of care are and 9 whether Ohio law requires hospitals to 10 follow hospital standards of care. You 11 have completely missed the applicability 12 of his testimony. 13 MS. CARULAS: I'll get to it. 14 Trust me, I'll get to it. 15 MR. KULWICKI: Yes. I mean, 16 it's just you haven't asked a single 17 question so far that goes to this 18 expert's credentials to testify as an 19 expert in this case or as to his opinions 20 in this case. We've been here for two 21 hours. 22 MS. CARULAS: I respectfully 23 disagree. But that is a point of 24 discussion later. Okay? 25 Let me go on. 0083 1 BY MS. CARULAS: 2 Q. So as far as evidence in the 3 file that he was told about risks or that there 4 was something out there aware of risks -- 5 MR. KULWICKI: Let me have an 6 objection to this line of questioning, 7 because this expert isn't here to define 8 who is telling the truth and who is not 9 tell the truth. And he is not here to 10 give medical opinions whatsoever. 11 He's here to testify about 12 hospital standards of care as a medical 13 ethicist, period. 14 MS. CARULAS: You may have an 15 objection. Noted. 16 BY MS. CARULAS: 17 Q. So we know there's mention on 18 the Web site of risks, correct? 19 A. Yes. 20 Q. Did you see documentation in any 21 of the Hawaii physician records that 22 Mr. Sullivan was told about risks, that there 23 are risks to this procedure? 24 A. I would have to look at them 25 again. I was struck that some of the 0084 1 statements about risks seemed to be a little 2 different in Hawaii than they were in Ohio, the 3 levels of risk, the nature of the procedure. 4 There seemed to me to be some variance there 5 that would concern me, if we ever could talk 6 about that. 7 Q. What was that? 8 A. Well, if -- if you were giving 9 me a case like this in a conference in a 10 medical school, and you would describe it, the 11 idea that he would have been -- information 12 would have been provided to him in Hawaii that 13 didn't look to me like the same information 14 that he got in Cleveland and then he flies to 15 Cleveland, obviously, in a vulnerable 16 condition, emotionally vulnerable as well as 17 medically involved, I would have to say that I 18 have real worries, I have great worries about 19 the extent to which he was able to make a fully 20 voluntary decision about whether to have this 21 procedure under the circumstances. 22 This is what worried me about 23 the use of the word "awareness," because our 24 awareness -- one of the things that worried me 25 before is, our awareness is so compromised by 0085 1 fear when we're sick. 2 And so how he actually 3 integrated information, did he have enough 4 time, was there -- was there a comfortable 5 situation which he could reflect on whether he 6 wanted to go ahead, I don't see that here. 7 And that goes to the core of my 8 views about this case based on the information 9 that I had. 10 Q. Tell me -- and we're going to 11 get to the other evidence in the chart that he 12 was aware of risks -- but tell me, what is it 13 in the prior Hawaii records that concerned you 14 or worried you about his awareness? 15 And, again, I object to the 16 whole nature of it. But go ahead. 17 A. Right. So I'm not commenting on 18 the awareness question. 19 You have a serious illness and 20 you're on one side of the planet. And 21 you're -- the notion is that you're going to go 22 somewhere very far away in the hopes of having 23 some kind of beneficial intervention, those 24 folks in the original site need to give you all 25 of the same quality of information that you 0086 1 would get when you're making that emotional 2 commitment to go to that other place. 3 And I -- the idea of the nature 4 of the procedure, I believe it was given a 5 different name in Hawaii. The risks, I saw 6 different levels of risks cited in Hawaii and 7 then apparently on site. It was very hard to 8 tell. 9 This is -- this was a -- 10 Q. Show me. I want to know the 11 specifics. Where is it that the name of the 12 procedure was different and where the risks 13 were described as different? 14 A. I'd have to go back and look at 15 the documents. 16 (Pause) 17 Q. I'll help you. These are the 18 Hawaiian records over here. 19 A. I wasn't sure. Like Hawaii and 20 Ohio, they're in two different places. I'm 21 looking for the report of the conversation that 22 he had. 23 (Pause) 24 I have to go back and find the 25 description. 0087 1 (Pause) 2 Dr. Shen uses the term, 3 "curative ablation." I'm really concerned 4 about the word "curative," but . . . 5 Q. What is Dr. Shen's specialty, do 6 you know? 7 A. I gather he's a cardiologist. 8 Q. Do you know if he had any 9 subspecialty? 10 A. I guess it was interventional 11 cardiology. 12 Q. He's an electrophysiologist? 13 A. I take that he was an 14 electrophysiologist. 15 Q. Do you know the difference 16 between an electrophysiologist and an 17 interventional cardiologist? 18 A. So, in general, 19 electrophysiologists use devices that involve 20 giving electrical impulses to an organ. 21 Q. From a layperson's perspective, 22 you know that there is a big difference in 23 subspecialties between an interventional 24 cardiologist and an electrophysiologist, 25 correct? 0088 1 MR. KULWICKI: Objection. 2 A. Well, there's a little -- I'll 3 take your word for it. There's a little 4 overlap. 5 BY MS. CARULAS: 6 Q. They're both cardiologists, but 7 then -- 8 A. Some people do both, as far as I 9 know. But there are cardiologists who do 10 electrophysiology interventions, right. 11 Q. You know that they have 12 separate -- 13 A. Boards. 14 Q. -- fellowship training and 15 separate boards, correct? 16 A. Yes. I'm looking for a 17 particular letter. Sorry to take this time. 18 Q. Just the record should reflect 19 that I'm allowing you time to -- I don't know 20 how long it's been now, five to ten minutes. 21 Your looking through the documents to find -- 22 you said that you thought there was -- 23 A. I recall that there was a 24 description of the procedure that looked 25 different to me. 0089 1 But, you know, I'm not here as a 2 medical expert. So it wasn't something that I 3 focused on. 4 Q. So you cannot comment -- 5 A. I'm sorry. 6 Q. You cannot comment that there 7 was some difference or trouble between what was 8 described to him by his 9 cardiologist/electrophysiologist in Hawaii and 10 what was described to him in Cleveland? 11 A. My recollection is, it was 12 different. But I'm looking through the 13 documents now. It's not something that I 14 focused on when I was reading the documents. 15 It's something I recall that's come up in 16 conversation with us. 17 Q. Again, because you are a 18 layperson in this medical realm, you would 19 defer to the electrophysiologist to discuss 20 this issue of the nature of the procedure and 21 how it's described -- 22 A. Yes. 23 Q. -- fair? 24 A. Yes. 25 Q. All right. Let go back, if we 0090 1 can, to my question about whether or not there 2 was some discussion as far as risks. 3 Are you aware that Dr. Hong 4 described that he discussed, "The potential 5 risks and complications were reviewed in detail 6 with Mr. Sullivan"? 7 Do you recall seeing that? 8 A. That's what he said. 9 MR. KULWICKI: Objection. 10 BY MS. CARULAS: 11 Q. And then we've talked about the 12 discussion with Dr. Burkhardt. 13 Are you aware whether or not any 14 other individuals at the Cleveland Clinic 15 discussed the nature of the procedure and the 16 potential risks of the procedure, and, in 17 particular, the risk of stroke, with 18 Mr. Sullivan? 19 MR. KULWICKI: Are you asking if 20 he has personal knowledge or if he 21 reviewed their testimony claiming that 22 they had that conversation? 23 A. I'm aware that there are people 24 who said that they had had those discussions. 25 BY MS. CARULAS: 0091 1 Q. Who in particular are you aware 2 of based on the evidence in this case? 3 A. I believe Nurse Poe referred to 4 a couple of people who had had that -- those 5 discussions. Was it Burkhardt and -- I can't 6 remember if it was Kanj, who she claimed had 7 those discussions. 8 Q. Do you recall that Stacy Poe 9 testified that she herself describes the nature 10 of the procedure and gives a handout with risks 11 written on the side specifically to the 12 patient? 13 Do you recall that testimony? 14 A. I recall that she said she did 15 that and that she was doing a reconstruction 16 from memory of that document. I don't know 17 that I ever saw that original document. 18 Q. And then you recall Dr. Kanj's 19 testimony as well, that he reiterated, and also 20 on the morning of the procedure made sure, that 21 the patient had been consented by Dr. Burkhardt 22 and then also mentioned that there are risks, 23 including the risk of stroke, correct? 24 A. That's what he testified. 25 Q. Again, I know you're not a 0092 1 medical professional, but as a layperson, if 2 you're permitted to give testimony in this 3 case, would you agree that most people realize 4 that with any surgery, there are risks? 5 MR. KULWICKI: Objection. 6 A. I guess the word "realize," like 7 the word "awareness," is pretty loaded. 8 When people are in a position of 9 badly needing intervention, they do tend to 10 turn down the volume on risks. 11 And, therefore, it's 12 particularly important that it be made very 13 clear to them in writing, something that they 14 have to commit themselves to in writing, that 15 they are aware of those risks; that they have 16 taken those risks into their decision. 17 BY MS. CARULAS: 18 Q. So it is not unusual for 19 patients -- I mean, whether they are given the 20 risks in detail verbally or even in a piece of 21 paper, the tendency is to turn down the volume, 22 because nobody ever wants to think that that 23 risk will happen to them? 24 MR. KULWICKI: Objection. 25 BY MS. CARULAS: 0093 1 Q. Is that fair? 2 MR. KULWICKI: Objection. 3 A. That's -- that's exactly why 4 written consent forms are required, because it 5 helps to ensure that, in fact, what has been 6 said has been reduced to writing in a way that 7 the patient can see. 8 And the fact that a signed form 9 is not present in this case fails to satisfy a 10 very well-established standard that requires 11 that kind of level of patient commitment to -- 12 with a signature -- to ensure that level of 13 awareness. 14 Q. You, I'm sure -- and, again, I 15 object to you giving opinions on this 16 necessarily, but just so we have that all out 17 there -- you would agree that patients, in 18 regular practice, do sign consent forms that 19 they, quote, unquote, turn the volume down or 20 simply sign as well, true? 21 A. You know, it is true that 22 patients have a way of telling themselves that 23 they're going to accrue benefits that they 24 might not. That's why it is so important for 25 the consent process to be thorough, for it not 0094 1 to require any emotional commitment on the part 2 of the patient to going ahead with the 3 procedure. 4 We left the topic of the travel 5 of this patient to Ohio. I think that is quite 6 important. 7 So while it is -- the moral 8 burden on the institution and the doctors is 9 grave. And that involves ensuring that the 10 patient has the fullest freedom to decline to 11 go further. And that is very hard to guarantee 12 when the circumstances are as were the case for 13 Mr. Sullivan. 14 Q. Well, one can never guarantee 15 what you are saying as far as ensuring the 16 ultimate -- 17 A. There are -- 18 MR. KULWICKI: Wait. Objection. 19 Go ahead. 20 A. (Continuing) You have to be 21 very careful of slippage here. 22 To say that there is no 23 guarantee, while in one sense it is true, in 24 another sense it can give license to being 25 pretty sloppy and to putting people in a 0095 1 position where a reasonable person would have a 2 hard time sorting out risks and benefits, as I 3 think is the case in the scenario here. 4 BY MS. CARULAS: 5 Q. Let's go back. We know that 6 Mr. Sullivan met with three different 7 cardiologists in Hawaii and then contacted the 8 Cleveland Clinic, correct? 9 A. That's what the record shows. 10 Q. And you are aware that it was 11 Dr. Burkhardt's judgment, he documented that 12 this could be treated as a one tripper? Did 13 you see that in the notes? 14 A. I saw that phrase. 15 Q. We've already been through all 16 of this. You are not commenting on the medical 17 judgments of Dr. Burkhardt, correct? 18 A. I'm not commenting on his 19 medical judgments, no. 20 Q. Now, let me just go back, if I 21 can. And I understand you loud and clear that 22 you think there should be a written consent 23 form. And we've been through -- 24 A. A signed consent form. 25 Q. A signed, okay. 0096 1 A. Not that I think. But may I 2 say, this was the -- this was the standard at 3 the time in the field of medical ethics. And 4 this has been established for a very long time 5 before this period. 6 Q. Where is that codified? 7 A. Well, there are no organizations 8 that say that. But I would refer you to the 9 medical ethics literature that talk about 10 signed consent forms. And it's all over the 11 literature. 12 That's not a substitute for the 13 process. And you stated that -- you mentioned 14 the fact that informed consent is a process. 15 Q. Right. 16 A. But it is a critical -- I would 17 say there is absolutely conventional -- anybody 18 in medical ethics would have told you that you 19 need to get a signed consent form for a 20 procedure like this. 21 Q. All right. But, again, the 22 process, when you're talking about the process, 23 that is a process between the patient -- 24 A. The form -- 25 Q. Wait until I finish. 0097 1 A. I'm sorry. 2 Q. When you talk about a process, 3 you are talking about the process between the 4 physician performing the procedure and the 5 patient, correct? 6 A. That's correct. 7 Q. All right. So I understand, 8 we've talked about Ohio law and your opinion on 9 that. 10 You've said there is no 11 organization that specifically said you need a 12 written consent form. 13 Your basis for this is the 14 medical ethics literature, correct? 15 A. Correct. 16 Q. Do you know a medical ethicist 17 by the name of Paterick, P-a-t-e-r-i-c-k? 18 A. No. 19 Q. Would you agree with the 20 statement that the dialogue between patient and 21 physician is the essence of the informed 22 consent process? 23 A. I'd agree with that, as 24 memorialized in the consent form. 25 Q. So the memorialization in the 0098 1 consent form -- okay. 2 You would agree with the general 3 statement that the essence is the dialogue 4 between the physician and the patient? 5 A. Yes. 6 Q. You would agree that the 7 quantity and the specificity of the information 8 in that discussion should be tailored to meet 9 the preferences and the need of that individual 10 patient? 11 A. If circumstances require 12 tailoring, then it should be tailored. 13 Q. Now, would you agree with the 14 statement that informed consent is not a piece 15 of paper. It is a trust between physician and 16 patient, and to ignore that could leave you in 17 a heap of trouble? 18 A. I agree with the statement as 19 far as it goes. But it's not because of the 20 trouble for the doctor. It's because of the 21 failure to respect the patient. 22 Q. Right. But you would agree that 23 informed consent is not a piece of paper? 24 A. That -- that's -- the informed 25 consent form is a required memorialization of 0099 1 the informed consent process. It is part of 2 the process. 3 And I would say that there's 4 powerful psychological reasons to make that 5 part of the process. 6 None of the statements I've 7 heard so far say that you don't need a consent 8 form as part of the process. 9 Q. Right. We've been through Ohio 10 law. 11 A. Well, I'm not -- again, I can't 12 interpret Ohio law. And if you present me Ohio 13 law in an ethics paper, I would have to say, 14 well, I'm interested in the ethics, not the 15 law. 16 Q. Again, I think you have touched 17 on this. But you would agree that just because 18 there is a signed consent form by a patient 19 doesn't mean there was informed consent? 20 A. A signed consent form is a 21 necessary, but not sufficient condition of 22 informed consent. 23 Q. I understand your opinion, that 24 you think it's a necessary component. 25 But just having -- 0100 1 A. I'm telling you what the field 2 believes. The position of the field is, in 3 medical ethics, that it is a necessary, but not 4 sufficient condition. 5 Q. Do you know, sir, whether back 6 in 2006, there were any other institutions, any 7 other leading institutions across the country, 8 other than the Cleveland Clinic, who did not 9 use consent forms? 10 A. I would say if there were such 11 institutions, that that's worth a paper in a 12 scholarly journal, because that suggests 13 that -- that there have been serious failures 14 of medical ethics at major institutions. 15 Q. My question to you is, as to 16 what was -- 17 A. I don't have personal knowledge. 18 Q. You've got to wait until I 19 finish. 20 A. Sorry. 21 Q. That's all right. 22 Do you have any personal 23 knowledge whether any other leading 24 institutions across the United States did not 25 utilize written consent forms for their consent 0101 1 process in 2006? 2 A. No. And that wouldn't affect my 3 position on the ethics. 4 Q. But the answer is, no, you don't 5 know? 6 A. No, I don't know. And it 7 wouldn't affect my position on the ethics 8 question. 9 Q. All right. 10 A. Can I do a little history here? 11 There's a good reason that we reached this 12 position in the field that I'm describing to 13 you. And that is, 2,000 years of physician 14 discretion about what happens between them and 15 their patients. 16 I'm not saying that anybody did 17 anything inappropriate in this case, or that 18 anybody is misrepresenting what they said or 19 believe they said. 20 But what I'm saying is, there 21 were very good reasons to require a written 22 consent formed signed by a patient. 23 Q. And you're not saying that if 24 there was evidence of a written consent form 25 signed by Mr. Sullivan, that that would have 0102 1 changed this course or outcome at all? 2 MR. KULWICKI: Objection. 3 BY MS. CARULAS: 4 Q. I mean, you're -- 5 A. I have no way of speculating on 6 that counterfactual. 7 Q. Have there ever, to your 8 knowledge, been any studies on that subject of 9 whether or not a written consent form has 10 altered the course? 11 A. Well, it's difficult to run a 12 study like that because you're trying to 13 control for an alternative universe. 14 People have been very interested 15 in running studies like that. I don't know 16 that anybody has ever been able to design one 17 that would get the answer that one would be 18 looking for. 19 The reason to require a signed 20 consent form is not only that it might change 21 the course of treatment, but as a measure of 22 respect for the patient. 23 Q. Right. And I understand your 24 position. 25 You're not saying that at any 0103 1 time during the course of this interaction, 2 that Dr. Burkhardt or Stacy Poe or Dr. Kanj or 3 any of the folks at the Cleveland Clinic did 4 not have respect for Shannon Sullivan? 5 A. Oh, I'm sure that they respected 6 Shannon Sullivan. I'm certainly not calling 7 into question their personal morality or their 8 professional ethics. 9 The field has come around to a 10 standard of what counts as respect for the 11 patient with respect to informed consent. 12 And because of a history of 13 excessive physician discretion and a lot of 14 other factors as well, a signed consent form is 15 regarded as a necessary part of the process. 16 Q. I understand that's your 17 opinion. 18 A. Yes. 19 Q. You are giving your opinion here 20 as a medical ethicist, true? 21 A. Yes, ma'am. 22 Q. Or as a philosopher, correct? 23 A. I'm giving my opinion based on 24 30-plus years working in the field of medical 25 ethics. 0104 1 Q. And philosophy? 2 A. And philosophy and history of 3 medicine. 4 Q. Okay. The opinion you are 5 giving here, it's your personal opinion, it 6 does not have the sanction of the University of 7 Pennsylvania, per se? 8 A. No. 9 Q. As far as the compensation that 10 you're receiving from Mr. Kulwicki in this case 11 and that I will pay you for your time to learn 12 your opinions here today, do you keep that 13 personally or does it go to the University of 14 Pennsylvania? 15 A. Because we're using a room that 16 is at the University of Pennsylvania, I will 17 write that -- the check over to the University 18 of Pennsylvania for this deposition. 19 Q. So the deposition will go to the 20 university. But as far as -- 21 A. Will go to an account in the 22 Department of Medical Ethics. 23 Q. All right. The rest of the fees 24 that you earn from Mr. Kulwicki, from your 25 review and report and so forth, that's money 0105 1 you kept? 2 A. That's correct. 3 Q. Do you have a fee schedule or 4 no? 5 A. $300 an hour. 6 Q. Across the board, basically? 7 A. Yes. 8 Q. Are you aware of any studies 9 that have looked into what percentage of 10 patients actually read consent forms and digest 11 it or have awareness of it? 12 A. Yes. There are -- there are a 13 number of studies. Some studies indicate that 14 people don't read them right away, that they 15 read them later on. That they pull them out of 16 their purse or a briefcase and share them with 17 a relative. 18 People are all over the map in 19 terms of how they use consent forms. 20 But, again, the consequences of 21 the role of a consent form are not even the 22 principal issue for me. 23 Q. I mean, the bottom line to you, 24 you just think that as a matter of medical 25 ethics in respect to the patient, they should 0106 1 be given something in writing? 2 A. They should be asked to sign a 3 consent form. 4 Q. Again, I think as far as what 5 would be in the consent form -- and we touched 6 upon this earlier -- you would agree it can be 7 a subject of -- I don't like the word 8 "debate" -- but a subject of discussion and -- 9 A. And -- 10 Q. -- negotiation or dialogue. 11 There can be differences of opinions as to how 12 much should be in the form, how detailed or 13 general it should be? 14 A. There are often such 15 discussions. 16 Q. As to what the procedure is, 17 when it should be given to the patient and by 18 whom, that could be a subject of discussion as 19 well? 20 MR. KULWICKI: Objection. 21 A. This could -- could be a subject 22 of discussion among whom? I'm sorry. Who is 23 talking about it in the way that you're setting 24 it up? 25 BY MS. CARULAS: 0107 1 Q. Well, I guess that's a question. 2 Amongst medical ethicists, is 3 that something that could be discussed and have 4 different opinions on the subject? 5 A. I don't think that there's 6 anybody in medical ethics who wouldn't agree 7 that the -- that the person who is going to do 8 the procedure, the people who are directly 9 involved in the case, bear the responsibility, 10 primary responsibility. 11 People who are referring also 12 bear a responsibility to be accurate and 13 complete in their information that they provide 14 to the patient. 15 Q. Okay. So the people really 16 responsible for getting informed consent, in 17 your opinion, are the referring physicians, 18 they should have a dialogue, and then the 19 primary responsible physician? 20 MR. KULWICKI: Objection. 21 BY MS. CARULAS: 22 Q. I mean, we've been through this 23 before. 24 A. Yeah. I'm just -- I'm afraid 25 that the particular conditions under which 0108 1 Mr. Sullivan went to Ohio are getting washed 2 out in this exchange between us. 3 And so I do want to stipulate, 4 but I believe that there's the outstanding 5 issue about the way that he traveled for the 6 one tripper to the clinic. And the -- and the 7 burden that that placed on the consent process 8 and the -- and the possibility, which can I 9 think is a very serious one here, that he would 10 have felt emotionally committed to proceeding. 11 And that his awareness, as you put it, of the 12 risks and benefits might have been compromised 13 in a situation like that. 14 If you were to ask me, do I know 15 that for a fact? I would say no. I'm 16 commenting as if he were presenting the 17 scenario to me in a case conference. 18 Q. Okay. So you're saying the 19 potential or the possibility exists of this 20 feeling of being too committed to the procedure 21 or this decreased awareness? 22 MR. KULWICKI: Objection. 23 A. Considering the vulnerability of 24 somebody in his situation, I believe it is a -- 25 and I believe that my colleagues would agree, 0109 1 that this places a big burden on the consent 2 process. And that it is hard for somebody in 3 that kind of situation to see matters as 4 clearly as he might if he hadn't made the trip 5 and made the emotional commitment to being 6 there. 7 BY MS. CARULAS: 8 Q. Well, you would agree that when 9 someone gets on a plane and -- I mean, first of 10 all, you know that Shannon Sullivan did a 11 significant amount of research about this 12 beforehand? You saw that? 13 MR. KULWICKI: Objection. 14 You can answer. 15 A. I'm not sure what "significant 16 amount of research" means. Maybe you could 17 tell me what you think that means. 18 BY MS. CARULAS: 19 Q. Yes. Are you aware that he 20 became educated on the procedure itself? 21 MR. KULWICKI: Objection. 22 A. There -- there is so much stuff 23 out there, especially now because of the Web, 24 that I'd be very uncomfortable with the notion 25 that somebody could self-educate in a situation 0110 1 like this. 2 BY MS. CARULAS: 3 Q. You're aware that he met with a 4 number of different cardiologists? 5 A. Yes. 6 Q. And specifically 7 electrophysiologists who discussed the 8 procedure with him? 9 MR. KULWICKI: Objection. 10 That's a gross misrepresentation of the 11 facts. 12 You don't know that. You don't 13 know what they say. You know what they 14 documented, but you don't have a clue 15 what they said. And in fact, they 16 documented that they were discussing the 17 Maze procedure. 18 So a completely different 19 procedure, Anna. So you're grossly 20 misrepresenting the facts to this 21 witness. 22 MS. CARULAS: I move to strike. 23 That's absolutely not true. And if 24 anyone looks at the records, it's pretty 25 darn obvious. 0111 1 But we have here about another 2 hour to get going. So you can argue your 3 perspective on this as long as you want 4 at a later time. 5 BY MS. CARULAS: 6 Q. You are aware that he had 7 discussions with three different cardiologists, 8 two of whom are electrophysiologists, correct? 9 A. I'm aware he had discussions. 10 Q. And you would agree that getting 11 on a plane and coming to Cleveland for a 12 procedure shows -- or do you know, does it 13 show a level of commitment to wanting the 14 procedure? 15 A. It shows a level of commitment 16 to being made better. 17 Q. Yes. 18 A. And that's perfectly 19 understandable. And I would feel exactly the 20 same way. I'd want to be made better. 21 Q. Okay. 22 A. And wanting to be made better is 23 such an overwhelming emotion when you're ill, 24 that it's so critical not to set up a situation 25 in which that further compromises what is 0112 1 already a hard decision for somebody who's 2 sick. 3 This almost strikes me, frankly, 4 as -- it reminds me of the kind of medical 5 tourism that's going on now from one part of 6 the globe to another. 7 So it's a -- it puts a terrific 8 burden on our ethical standards to have people 9 moving around in this way when they're sick. 10 Q. All right. But I understand 11 your concern from a medical ethicist. And you 12 have expressed that, correct? 13 A. That's why I'm here, as a 14 medical ethicist. 15 Q. And we've been through whose 16 judgment this was and so forth. Okay, I 17 understand your statement. 18 So if you pull out your report, 19 I just want to go through some of the things 20 you've said here. 21 A. Sure. 22 Q. So number one, you talk about 23 the conventions and standards of medical 24 ethics. And you make the statement as far as 25 the need for an informed consent, correct? 0113 1 A. Yes. 2 Q. Again, we've talked about what 3 are the bases for that, and we talked about how 4 essentially the support for this is the 5 literature on medical ethics that we talked 6 about, correct? 7 A. Yes. 8 Q. Then number two, you say that 9 the conventions and standards of medical ethics 10 provide that this be reduced in writing, which 11 we've discussed -- 12 A. Right. 13 Q. -- correct? 14 A. Yes. 15 Q. And, again, the basis of this 16 what you have, quote, unquote, conventions and 17 standards of medical ethics is, as we 18 discussed, the medical ethics literature? 19 A. Yes. 20 Q. Now, number three, you say that, 21 "The ethical justification for the reduction of 22 informed consent to writing is that of 23 protecting and promoting the patient's right to 24 self-determination." 25 A. Yes. 0114 1 Q. What do you mean by "ethical 2 justification"? 3 A. I mean to distinguish it from 4 any legal requirement. 5 I'm not a lawyer, as we've 6 firmly established. So I'm not saying that 7 it's a legal -- I don't know if, in this 8 instance, it's a legal problem or not. 9 Q. Then you go on and say, "In 10 practical terms, a patient may not be able to 11 focus on verbal exchange due to the stress and 12 anxiety of illness"? 13 A. Uh-hum, as we discussed. 14 Q. We discussed that. As far as 15 being able to say it was a fact in this case 16 that Mr. Sullivan was not able to focus on a 17 verbal exchange due to stress and anxiety of 18 illness, you cannot say that. You're just 19 giving a general statement, correct? 20 MR. KULWICKI: Objection. 21 A. I am saying that a person in 22 this position would have a very hard time not 23 being influenced by the stress and anxiety of 24 their medical situation and -- well, I'll leave 25 it at that. 0115 1 BY MS. CARULAS: 2 Q. All right. But my question to 3 you -- you're talking general -- you are not 4 able to say that Mr. Sullivan personally was 5 not able to focus on the verbal exchange due to 6 stress and anxiety, true? 7 A. That's right. And that's not 8 what I say here. 9 Q. We're on the same page -- 10 A. Right. 11 Q. -- correct? Is that true, we're 12 on the same page? Am I understanding you? 13 A. I believe that what you just 14 said is accurate. I did not interview 15 Mr. Sullivan. I do not have personal knowledge 16 of his psychologic condition at that time. 17 Q. It then goes on and says that 18 the patient "may be cognitively or otherwise 19 impaired in ways that are not obvious but make 20 processing the information difficult." 21 As you've looked at his medical 22 records prior to the point of going to the 23 Cleveland Clinic, are you aware that 24 Mr. Sullivan, at the time he came to the 25 Cleveland Clinic, August 16th, August 17th, 0116 1 2006, was cognitively impaired? 2 A. I have no specific evidence to 3 show that he was cognitively impaired or 4 emotionally impaired. 5 Q. Then it says he may not be a 6 native English speaker. 7 We know that he was a native 8 English speaker? 9 A. Fine. 10 Q. Now, the whole point of informed 11 consent is that the patient understands the 12 risks, correct? 13 A. And understands them and 14 appreciates, which is taking them on board in a 15 way that lines up with their preferences and 16 values. 17 Q. I mean, that's the bottom line 18 to it, correct? 19 A. That's one bottom line. 20 Q. I mean, that's the goal? The 21 goal is, you want the -- 22 A. The goal is to make -- 23 Q. Wait, wait. Let me finish. 24 The goal is, at the end of an 25 informed consent discussion, that the patient 0117 1 understands the nature of the procedure, the 2 potential risks and the benefits -- 3 A. And -- 4 Q. -- and makes an informed 5 decision? 6 A. And to that list, I'd add and 7 the alternatives. 8 Q. And the alternatives, okay. 9 A. And to emphasize again, that his 10 self-determination is respected and promoted. 11 Q. And we've been through all of 12 that. 13 And you go on to say those above 14 things that we can't say were present in 15 Mr. Sullivan, that he wasn't an English 16 speaker, et cetera, all of these are obstacles 17 to self-determination that are at least partly 18 ameliorated by a consent form; is that correct? 19 A. Right. 20 Q. Now, there are circumstances 21 where a written consent form is not even going 22 to help at all in a patient's 23 self-determination in understanding the risks? 24 A. I'm not sure what circumstances 25 you're referring to. 0118 1 Q. Well, can you think of any 2 circumstances where a written form is not going 3 to partly help the process? 4 A. Well, in an emergency, it's 5 waived. You get what you can later on. If 6 somebody is too young or has a dementia or is 7 otherwise unable to participate in the process, 8 then there has to be a surrogate 9 decision-maker. 10 Q. If the patient is illiterate? 11 A. No. Literacy is not a 12 condition. They can be explained verbally. So 13 the fact that somebody is illiterate or is not 14 an English speaker -- or a speaker of the 15 current language should not be an issue. 16 Q. In the case of a patient who is 17 illiterate, is an informed consent discussion 18 an alternative, a viable alternative, a verbal 19 discussion? 20 A. In the case of somebody who is 21 illiterate, we still ask them, at the very 22 least, to make a mark that will indicate that 23 they have been a participant in a discussion. 24 Q. And the point of that is for the 25 evidence of it essentially? 0119 1 A. Well, no. It's more than that 2 time. It's not a legal question for me. 3 Q. All right. Number four, you 4 say, "The only evidence of informed consent I 5 have seen is a signed statement by the 6 physician that such consent was obtained." 7 A. Yes. 8 Q. We've since gone through at 9 least a list of other evidence, as one would 10 look at the facts of the case, of discussions 11 of the risks, true? 12 A. You know, they -- I believe that 13 people believe that they did those things. But 14 for me, it really needs to be a signed consent 15 form. And that is the view in the field. 16 Q. Of medical ethics? 17 A. Yes. 18 Q. Then you're going through and 19 say, the act of signing a consent form should 20 also be witnessed by a third party. 21 Do you believe the third party 22 needs to sign it? 23 A. Normally, that is the 24 expectation. 25 Q. You're not here to talk about 0120 1 whether the law requires a third party 2 signature. 3 Do you believe that the 4 conventions of medical ethics require a 5 third-party signature? 6 A. I would say that's a little 7 weaker. It is a preference. But it's not the 8 kind of requirement that I would say a signed 9 consent for a patient is. And that's partly 10 because of this complication that the patient 11 may not have capacity, and, therefore, the 12 surrogate would have to give consent, 13 permission. 14 Q. All right. Then you're saying 15 you think, number six, they should get the copy 16 to take with them? 17 A. Yes. 18 Q. All right. Then number seven, 19 you say that a signed consent form, in your 20 opinion, is necessary, but not a sufficient 21 condition. 22 And we've been through that 23 before. You need to have the discussion? 24 A. Yes, ma'am. 25 Q. And you go on and say precisely 0121 1 that, that it's a process. It's not a discrete 2 piece of paper or event? 3 A. Well, it's not -- it is a 4 discrete piece of paper. It is not a discrete 5 event. 6 Particularly, in a situation, 7 what I gather, has involved a period of time 8 and changes in his condition. So that is an 9 ongoing -- should be an ongoing discussion. 10 Q. You go on and make the 11 statement, "If the relevant medical 12 circumstances change between preoperative 13 evaluation and the procedure itself as in this 14 case where Mr. Sullivan's INR changed and 15 thereby altered the risk-benefit ratio of the 16 procedure, then the informed consent process 17 should reflect that change. I have seen no 18 evidence to that effect." 19 Did I read that correctly? 20 A. Yes. My recollection is that 21 that data changed in the process and that I saw 22 that change in the documents. 23 And that's why I have this 24 impression, that the process should have 25 reflected -- well, it should have reflected 0122 1 some changes in his condition. 2 Q. Okay. And, again, you are not 3 qualified to say if the issue with the INR 4 reflected a change in the patient's condition 5 or not? 6 A. I'm not, no. 7 Q. And you are not qualified to 8 comment on how an electrophysiologist would 9 address that? 10 A. No. 11 Q. Or what they would say in detail 12 as far as that, correct? 13 A. No. 14 Q. And you cannot comment on what 15 substantively should have been told to Shannon 16 Sullivan about that? 17 A. No. Only that if the 18 circumstances changed, that discussion should 19 have reflected the change. 20 Q. And you're not saying that it 21 didn't? 22 A. I'm sorry, the "it" refers to? 23 Q. Yes. You're not saying that the 24 whole issue of the patient's INR was not 25 discussed by Dr. David Burkhardt? 0123 1 A. Well, as I recall, the INR was 2 discussed. I don't -- when I wrote this, I had 3 the impression that there was some change over 4 the period of his treatment. Now, again, if 5 that was the case, then that should have been 6 discussed. 7 Q. And you're not commenting one 8 way or the other, if it was, if it wasn't, or 9 the details of that? 10 A. No. 11 Q. Number eight, you say, "The 12 absence of an informed consent form for surgery 13 also deprives the reader of information that 14 could clarify the extent to which the proposed 15 procedure is innovative." Okay? 16 A. Uh-hum. Yes. 17 Q. You, as a medical ethicist, 18 cannot comment whether or not this procedure 19 was, quote, unquote, innovative or not? 20 A. I saw it described as novel or 21 innovative in some of the documents that I was 22 given. If that's the case, then this statement 23 applies. 24 Q. Again, what specifically 25 Dr. Burkhardt should have said to Mr. Sullivan 0124 1 as far as the nature of this procedure, if it 2 is considered by electrophysiologists to be 3 innovative or not, you can't comment on what 4 the substance of that would be -- 5 A. That's correct. 6 Q. -- correct? 7 I would like you, if you would, 8 just to -- I'm going to look at my notes. I 9 would like you to just read over this document, 10 please. 11 MS. CARULAS: I'm showing him 12 the report of Dr. Callans. 13 MR. KULWICKI: Oh, okay. 14 (Pause) 15 BY MS. CARULAS: 16 Q. Okay? 17 A. Hmm. 18 Q. You've read it quickly. 19 A. Well, most of it is of a 20 technical nature. And I don't hold myself out 21 as an expert on the technicalities. 22 Q. And you, at the end of reading 23 it, did a -- I don't know how to put it on the 24 record, a "hmm," a "hmm." 25 What was the "hmm" for? 0125 1 A. Well, the writer is reaching a 2 conclusion about what Mr. Sullivan was not 3 repeatedly advised about. And I'm wondering, 4 as you might, how the writer knows that. 5 That's this paragraph. "It is 6 impossible to believe that Mr. Sullivan . . ." 7 I'm just not sure what to make of that. And 8 that may be true. But it also may not be 9 accurate. 10 Neither the writer nor I were 11 present. 12 Q. Okay. The writer, Dr. Callans, 13 is someone who, in his day-to-day practice, has 14 interactions with patients and informed consent 15 discussions about undergoing this particular 16 procedure. 17 You're aware of that? 18 A. Yes. 19 Q. Let me just state the obvious. 20 He has much more experience in 21 interacting with patients and having informed 22 consent discussions on this subject than you 23 do? 24 A. Lord knows. Yes. 25 Q. So that's absolutely true? 0126 1 A. Yes. 2 Q. So how to how to perform an 3 informed consent and you -- well, let me strike 4 that. 5 You say what he says, "It is 6 impossible to believe Mr. Sullivan was not 7 repeatedly advised about the possibility that 8 this procedure may not be successful or that 9 there were important potential complications, 10 including stroke." 11 You said that may indeed -- 12 A. I don't know what's possible for 13 one person to believe and what is possible for 14 someone else to believe. I would only say that 15 it's possible to believe that he wasn't. 16 Q. Well, I suppose anything in life 17 is possible? 18 A. Indeed. That's why I think that 19 statement is not all that helpful. 20 Q. But with you not being someone 21 who interacts and knows whether or not stroke 22 is something that is repeatedly advised as a 23 complication of this procedure, it's difficult 24 for you to comment? 25 A. Well, that's a statement about a 0127 1 particular set of interactions and about what 2 the writer, you know, believed or did not 3 believe that something happened. It's not 4 really about his practice and informed consent 5 in this procedure. 6 Q. Well, I would think that 7 electrophysiologists know what it is that they 8 say to patients as far as, you know, this is 9 what, unfortunately, can happen with this 10 procedure. 11 A. I'm only concerned about the 12 notion that it's impossible to believe 13 something, when clearly different people may 14 believe different things. 15 Q. All right. 16 A. Just I don't know that that's 17 all that helpful. If this is the physician's 18 report of what is conventionally done, I have 19 no reason to doubt that that is true, that that 20 is what is conventionally done. 21 But the question of belief is a 22 different one in this particular case. And 23 whether it's possible to believe something was 24 done or not done at all is a different 25 question. 0128 1 Q. Your getting too philosophical 2 for me. 3 A. No, you're too smart for that. 4 MR. KULWICKI: I'm going to 5 object and move to strike. I think, you 6 know, the denigrating tone is 7 inappropriate. 8 And I think, you know, you're 9 trying to get Dr. Callans to vouch for 10 the credibility of Dr. Kanj and Nurse Poe 11 and Dr. Burkhardt. And that's 12 inappropriate under Ohio law. It just 13 is. 14 BY MS. CARULAS: 15 Q. You didn't think I was trying to 16 denigrate you, did you? I was just having fun. 17 A. I want to stay out of it. 18 Q. Okay. 19 A. I feel fine. 20 Q. Good, I'm glad. 21 All right. Now, this whole 22 discussion, I know you say you have some 23 interest in innovative surgeries. 24 And you've already said you 25 don't know to what extent this would be 0129 1 considered innovative or not. 2 A. Only that I've seen references, 3 in the papers I was given, to the procedure as 4 novel or innovative. 5 Q. All right. Now, as far as this 6 whole issue about whether or not Mr. Sullivan 7 was in a research study, did you see any 8 evidence that he was enrolled in any type of a 9 research study? 10 A. You know, it looks as though 11 his -- his data were entered into the registry. 12 And I'm trying -- I -- I'm trying not to reach 13 a conclusion about whether his data was 14 identifiable or not. That's to say whether it 15 was -- the data that was entered in the 16 registry was linkable to him as a person. 17 Q. Okay. 18 A. And I -- it wasn't clear to me, 19 and it's still not clear to me. 20 I simply wanted you to know that 21 if it was identifiable, that makes him a 22 research subject, and that requires special 23 consent to be in a research study. 24 Q. Okay. Again, I'm a layperson. 25 But as far as a research study, 0130 1 the type where there's an experiment of sorts 2 where there's two different arms and people are 3 randomized and all that sort of thing, where 4 there's a big long IRB consent form, you didn't 5 see any evidence that Mr. Sullivan was enrolled 6 in that type of a research study, correct? 7 A. No, he was not -- I didn't see 8 any evidence that he was involved in a 9 randomized control trial. 10 There are these trials that 11 are -- that are -- there are studies that 12 are -- that are attempts to gather what are 13 essentially epidemiological data from which one 14 may be able to draw conclusions if the number 15 of similar patients with similar conditions is 16 large enough, complete enough. 17 And that is what I gather part 18 of this AFib registry is. 19 Q. You know that oftentimes 20 databases are kept by hospitals or departments 21 for a number of different reasons; is that 22 correct? 23 A. Yes. 24 Q. They do it for quality assurance 25 reasons, correct? 0131 1 A. Yes. There are quality 2 assurance records that are not -- registries 3 that are not required to be treated as research 4 studies. 5 Q. And oftentimes you keep 6 information for insurance purposes, obviously? 7 A. Yes. 8 Q. Certain organizations, watchdog 9 organizations, want you to have certain 10 information so they can look back? 11 A. Yes. 12 Q. They want databases for that? 13 A. Yes. 14 Q. And those type of purposes, you 15 don't necessarily need to get IRB approval or 16 you could get an IRB waiver or all that, true? 17 A. Well, sometimes registries -- I 18 mean, a registry could turn into something that 19 could be regarded as a research study if it -- 20 if they're published in such a way as to 21 influence the knowledge of the field. 22 At that point, you have to 23 certainly be sure that you've made all the 24 personal records non-identifiable. 25 Q. Okay. Oftentimes, hospitals, 0132 1 you know, they keep data for their outcomes and 2 to have some handle on things? 3 A. Yes. 4 Q. And oftentimes you have like a 5 look-back? 6 A. That's the term that's used. 7 Q. And oftentimes you can look back 8 at someone's individual hospital chart or you 9 could look back at kind of a summary of that? 10 A. Yes. 11 Q. So what I want to understand, I 12 mean, you are not -- maybe I need to find out 13 if you are saying this. 14 But, I mean, you've talked about 15 the consent form here that you think, 16 hypothetically, should have been -- we know 17 about the consent form. But you're talking 18 about a consent form. 19 I just want to make sure before 20 I leave here. I mean, you're not saying that 21 the Cleveland Clinic or the electrophysiology 22 department or Dr. Burkhardt was acting 23 unethically at all in their research and 24 publication? I mean, am I fair? 25 MR. KULWICKI: Objection. 0133 1 You can answer. 2 A. I'm talking here about policies 3 and procedures. I'm not talking about an 4 individual person's ethics. That's what I'm 5 talking about. 6 BY MS. CARULAS: 7 Q. All right. I mean, you're -- 8 A. Unfortunately, what -- so the 9 word "ethics" is sometimes understood to be a 10 reference to somebody's moral disposition, kind 11 of, whether they're a good or bad person. 12 Q. Right. 13 A. And the way that people in this 14 field use the word "ethics," it's a question of 15 standards, conventions, principles. 16 Those conventions, standards and 17 principles are created because good people 18 sometimes don't know what other good people 19 have agreed, as a matter of consensus, ought to 20 govern the practice. 21 And so I'm not using -- when I 22 say that there was a violation of medical 23 ethics, I'm not calling anybody's personal 24 ethics into question. I'm talking about the 25 conventions and standards of the field. 0134 1 Q. So you're saying that if a 2 registry is maintained for a purpose other than 3 what we've talked about -- 4 A. Yes. 5 Q. -- it needs to, in your opinion, 6 go to an IRB? 7 A. Yes. 8 Q. And then an IRB, in your 9 opinion, needs to either require a consent form 10 or they can waive that? 11 A. If -- 12 MR. KULWICKI: Objection. 13 BY MS. CARULAS: 14 Q. I mean, I -- 15 A. Well, an IRB, if they are going 16 to waive consent, in general, they're going to 17 do that because the information has not -- is 18 not identifiable to -- is not linkable to a 19 particular individual. 20 Q. So, hypothetically, if there was 21 a consent form in this, which we know you think 22 there should be, and in your mind, if good 23 people are keeping registries to try to keep 24 data of, okay, we've done this many of this or 25 this many of that, what needs to be in the 0135 1 consent form about having a registry? 2 A. Well, if it's a research study, 3 then we need to tell you that your data may be 4 entered into a research study. It may be part 5 of a publication. It could be something that 6 ultimately leads to a product or a device or a 7 service that has commercial value. 8 But you will not participate in 9 enjoying the benefits of that commercial value. 10 You won't make any money from your data or your 11 tissues, or whatever it is, being part of this. 12 And that you understand that. 13 Now, in some cases, your data 14 may help us understand more about you 15 medically. You need to be told, whether you 16 will be contacted or whether the whole group 17 will in some way be notified, that something 18 has been learned that's important for you 19 medically or for your family. 20 These are the kinds of things 21 that would need to be in the consent form. 22 Q. Right. And, again, I mean, do 23 you have an opinion in this case or are you 24 going to say at some later time that you think 25 that the consent form for Shannon Sullivan 0136 1 should have included all of those issues or -- 2 A. Well, if this qualifies as 3 research and if his data was not de-identified, 4 then I would say that should be a separate form 5 and process. 6 Q. Then what would hypothetically 7 be in that separate form? 8 A. Well, what I've described to 9 you. 10 Q. Depending if it was applicable 11 or not, right? 12 A. Yes. 13 Q. I mean, you mentioned something 14 about tissue samples or -- 15 A. Right. No. It would obviously 16 depend on the nature of the registry, sure. 17 Q. Are you able to give any more 18 specifics as to what, hypothetically, you think 19 should have been in a separate form? 20 A. It would depend very much on 21 what people were looking for in the registry, 22 what conclusions they would want to draw on. 23 Q. Beyond that hypothetical, you're 24 not giving any specific opinions in that 25 regard; is that -- 0137 1 A. That's correct. 2 Q. And you are not giving any 3 opinions as to whether or not that information 4 would have affected Shannon Sullivan's decision 5 to consent? 6 MR. KULWICKI: Objection. 7 That's not within his expertise. So I 8 object. 9 A. It's a kind of factual I don't 10 know how to evaluate. 11 BY MS. CARULAS: 12 Q. Okay. I just want to make sure 13 you will not be saying, at the time of trial, 14 that you believe that had he hypothetically 15 been given a separate consent form saying, we 16 may look at your data later to see if it will 17 help others or whatever these other situations 18 are, you aren't going to say that that would 19 have affected a reasonable person's judgment in 20 this case? 21 MR. KULWICKI: I object. It's 22 not a matter for expert testimony. 23 However, Doctor, you can answer. 24 BY MS. CARULAS: 25 Q. Fair? 0138 1 A. I -- I'm not mainly or -- 2 concerned about the consequences of the consent 3 form. I'm mainly concerned about the need to 4 respect the patient by having a signed consent 5 form. 6 Q. I mean, this all goes in with 7 what we've been talking about the whole time, 8 the respect for the patient? 9 A. Indeed. 10 Q. Then number ten, you say, "I 11 further note that remote magnetic navigation 12 was used in the course of Mr. Sullivan's 13 pulmonary vein ablation procedure." And then 14 you go on to say, "It's an innovative practice 15 and as such its use should be disclosed to the 16 patient." 17 I think we touched upon this a 18 couple hours ago, that you don't have any 19 specific understanding as to how one uses 20 magnetic navigation in a pulmonary vein antrum 21 isolation procedure? 22 A. I do not. 23 Q. And you would defer to the 24 electrophysiologist, such as Dr. Burkhardt, 25 Dr. Callans, as to what should be relayed to a 0139 1 patient about magnetic navigation? 2 MR. KULWICKI: Objection. 3 A. Yes. With the framing condition 4 that I had mentioned about namely that how one 5 expresses it is of concern to me. What the 6 literature says, what the science says, I would 7 defer to the physician or scientist. 8 BY MS. CARULAS: 9 Q. As to what the details are. You 10 know, I understand. We can beat a dead horse. 11 A. Right. 12 Q. Have we covered all of your 13 opinions in this case as to your opinions on 14 medical ethics in this case? 15 A. As we sit here at this moment, I 16 believe we have. 17 Q. If at any point in time you 18 review any additional materials or come up with 19 any additional opinions on the issue of medical 20 ethics, will you relay that to Mr. Kulwicki, so 21 I am advised of it? You'll write a supplement 22 report? 23 A. Yes, ma'am. 24 MS. CARULAS: So we've been here 25 now for two-and-a-half hours, right? So 0140 1 what you can do is, you can bill me. You 2 know, you can do a separate bill, one for 3 the deposition, and send to it 4 Mr. Kulwicki. He'll send it on to me. 5 Okay? 6 And you have the right to read 7 over the transcript or you can waive 8 that. 9 MR. KULWICKI: Now, before we 10 terminate the deposition. I'm going to 11 ask you some questions, just because I 12 anticipate defense counsel raising a 13 motion before the court at some point in 14 time. 15 MS. CARULAS: I'm going to note 16 an objection to this. It's my discovery 17 deposition. But I will let you go ahead. 18 - - - 19 EXAMINATION 20 - - - 21 BY MR. KULWICKI: 22 Q. Doctor, you prepared a report, 23 which is marked as, I believe, Exhibit G. 24 Does that set forth the opinions 25 relative to this matter? 0141 1 A. It does. 2 Q. Are those opinions stated to a 3 reasonable degree of professional probability 4 or certainty as a medical ethicist? 5 MS. CARULAS: Objection. 6 A. Yes, they are. 7 BY MR. KULWICKI: 8 Q. Oh, before I go on. Your CV was 9 marked as Exhibit H. 10 Is that a true and accurate copy 11 of your professional credentials that support 12 your qualifications to render opinions as a 13 medical professional, a medical ethicist? 14 A. Yes, sir. 15 MS. CARULAS: Objection. 16 BY MR. KULWICKI: 17 Q. Now, in the field of medical 18 ethics, is there a clinical component to that 19 that falls within the rubric of a medical 20 professional or a health care professional? 21 MS. CARULAS: I'm going to 22 object. He's previously said he is not a 23 medical professional. 24 But go ahead. 25 BY MR. KULWICKI: 0142 1 Q. You can answer it. 2 A. So there are courses, there's 3 literature, there are services provided and 4 paid for by hospitals that have to do with 5 clinical ethics. There are ethics committees 6 and ethics consultants that are now part of the 7 professional standard and the institutional 8 policy standard throughout the United States. 9 Q. With respect to the professional 10 activities of clinical ethicists -- well, first 11 of all, you have fulfilled that role in the 12 past? You've been a clinical advisor to 13 physicians and hospitals -- 14 A. And to hospitals. 15 Q. -- correct? 16 And with respect to background 17 and training, are you qualified, based on your 18 CV and all the materials put in there and your 19 background as having been a clinical ethicist, 20 to render opinions regarding, as you say, 21 conventions, standards, policies and procedures 22 applicable to a hospital like the Cleveland 23 Clinic in terms of the form of informed 24 consent? 25 MS. CARULAS: Objection. 0143 1 A. Well, I've been asked to speak 2 at and advise numerous organizations, including 3 hospitals and medical schools and medical 4 centers. And I will let my record speak for 5 itself. 6 BY MR. KULWICKI: 7 Q. Would you agree, though, with 8 the statement that you are qualified to render 9 the opinions that you set forth in your report? 10 MS. CARULAS: Objection. 11 A. I would agree that I am 12 qualified. 13 BY MR. KULWICKI: 14 Q. Now, you were asked quite a bit 15 about your background in philosophy when you 16 were doing your formal education. 17 Was there a program dedicated to 18 medical ethics anywhere? 19 A. The field really got established 20 around the time that I finished my Ph.D. And I 21 was one of the first people in the field in the 22 late 1970s. 23 Q. In terms of teaching medical 24 ethicists today to go out and be advisors to 25 hospitals regarding matters of clinical medical 0144 1 ethics, are you currently involved in training 2 at, in fact, the largest institution that 3 trains medical ethicists today? 4 MS. CARULAS: Just a continuing 5 objection. 6 A. I am. I am a member of the 7 faculty of the master's program in bioethics. 8 And I teach medical students as part of my role 9 here at Penn. 10 BY MR. KULWICKI: 11 Q. In terms of the folks who you 12 teach, do you teach both ethicists and 13 physicians about medical ethics and how the 14 conventions, standards, policies and procedures 15 of a hospital would incorporate aspects of 16 medical ethics? 17 MS. CARULAS: Objection. 18 A. I teach physicians-in-training, 19 physicians, lawyers, lawyers-in-training versus 20 social workers, people who are working for 21 pharmaceutical firms. Just about everybody you 22 could think of. 23 BY MR. KULWICKI: 24 Q. Do you lecture to doctors 25 currently? I mean, is that part of the thing 0145 1 that you do to advise them about issues in 2 medical ethics that might apply to hospital 3 conventions, standards, policies and 4 procedures? 5 A. Yes, it is. 6 MS. CARULAS: What I'm going to 7 do is, I'm just going to have a 8 continuing line to all of this, so I 9 won't have to interrupt you, as to the 10 leading nature and just the whole context 11 of it. 12 But go ahead. 13 BY MR. KULWICKI: 14 Q. Do you agree with that? 15 A. Yes. 16 Q. I'm almost done, Doctor. 17 Now, you were asked about 18 informed consent standards applicable to 19 electrophysiology procedures. 20 In the course of your training 21 and experience, have you ever heard of 22 particular informed consent standards that 23 apply specifically to electrophysiology 24 procedures that don't apply to any other 25 surgical procedures? 0146 1 MS. CARULAS: Objection. 2 A. No. 3 BY MR. KULWICKI: 4 Q. You were asked about state law 5 in terms of its applicability here with regard 6 to Ohio law. 7 In the course of your training 8 and experience, have you come to understand 9 about federal laws that apply to every hospital 10 in the United States with respect to different 11 aspects of informed consent? 12 MS. CARULAS: Just note an 13 objection. He's already said he is not 14 an expert in the law. 15 But go ahead. 16 A. I've come to be aware of and 17 have spoken, written about the federal 18 regulations with respect to informed consent in 19 human subjects research. 20 BY MR. KULWICKI: 21 Q. And to the extent that Ohio law 22 requires informed consent to be in writing and 23 to have certain elements, to the extent that 24 Ohio law requires hospitals, like the Cleveland 25 Clinic, to comply with accepted standards of 0147 1 hospital care, would you agree that you are 2 competent, qualified as a medical ethicist, 3 with your extensive CV, to comment on the 4 standards, conventions that apply to these 5 policies and procedures as determined by, you 6 know, nationally accepted standards of medical 7 ethics, federal law that applies, and also 8 standards of hospital administration in terms 9 of what's appropriate under the circumstances 10 of this case? 11 MS. CARULAS: Objection. 12 A. Yes. 13 MR. KULWICKI: All right. 14 That's all I have. Thank you. 15 MS. CARULAS: I have nothing 16 further. 17 MR. KULWICKI: Let's read. 18 - - - 19 (Witness excused.) 20 - - - 21 (Whereupon, the deposition was 22 adjourned at 1:45 p.m.) 23 - - - 24 25 0148 1 C E R T I F I C A T E 2 3 4 COMMONWEALTH OF PENNSYLVANIA: 5 COUNTY OF PHILADELPHIA: 6 7 I, CHERYL L. GOLDFARB, a Notary 8 Public within and for the County and State aforesaid, do hereby certify that the foregoing 9 deposition of JONATHAN D. MORENO, Ph.D., was taken before me, pursuant to notice, at the 10 time and place indicated; that said deponent was by me duly sworn to tell the truth, the 11 whole truth, and nothing but the truth; that the testimony of said deponent was correctly 12 recorded in machine shorthand by me, to the best of my ability, and thereafter transcribed 13 under my supervision with computer-aided transcription; that the deposition is a true 14 record of the testimony given by the witness; and that I am neither of counsel nor kin to any 15 party in said action, nor interested in the outcome thereof. 16 17 WITNESS my hand and official seal this 30th day of March, 2011. 18 19 20 _______________________________ 21 CHERYL L. GOLDFARB, RPR Notary Public 22 23 24 25